Cosmetic or dermatological composition comprising at least a merocyanine and a hydrotrope - Patent Application 20070229933
By incorporating hydrotropes like nicotinamide and caffeine, the solubility of merocyanine UV-screening agents in aqueous media is enhanced, addressing sensory issues and improving UVA protection in cosmetic compositions.
Patent Information
- Application Number
- JP2024535979
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-12-17
- Filing Date
- 2022-12-12
- Publication Date
- 2024-11-28
- Estimated Expiration
- 2042-12-12
AI Technical Summary
Existing photoprotective compositions containing merocyanine UV-screening agents face challenges with poor solubility in aqueous media, leading to sensory issues and inadequate protection against long-wavelength UVA radiation, particularly in compositions intended for skin care.
Incorporation of specific hydrotropes such as nicotinamide and caffeine into the aqueous phase of cosmetic compositions to enhance the solubility of merocyanine UV-screening agents, ensuring better sensory properties and effective UVA protection.
The use of hydrotropes improves the solubility and stability of merocyanine UV-screening agents in aqueous media, providing enhanced sensory comfort and effective photoprotection against UVA radiation without adverse cosmetic effects.
Smart Images

Figure 2024544301000001_ABST
Abstract
Description
[Technical field]
[0001] The present invention relates to the field of care and / or make-up for keratinous materials, in particular the care of keratinous materials, especially the skin.
[0002] In particular, the present invention relates to the field of sunscreens, and more particularly to photoprotective cosmetic or dermatological compositions dedicated to anti-UV protection of keratinous materials, having advantageous properties in terms of sensory perception and stability.
[0003] For the purposes of the present invention, the term "keratinous materials" refers in particular to the skin, the lips and / or the eyelashes, in particular to the skin and / or the lips, preferably to the body and / or face, more preferentially to the skin of the face. [Background technology]
[0004] It is known that radiation with wavelengths between 280 and 400 nm is capable of tanning the human epidermis, and that radiation with wavelengths between 280 and 320 nm, known by the name UVB rays, is harmful to the natural tanning process. Exposure is also likely to result in adverse changes in the biomechanical properties of the epidermis, which are reflected in the appearance of wrinkles and lead to premature aging of the skin.
[0005] It is also known that UVA rays, with wavelengths between 320 and 400 nm, penetrate deeper into the skin than UVB rays. UVA rays cause immediate and persistent tanning of the skin. Daily exposure to UVA rays under normal conditions, even for short periods, can result in damage to collagen fibers and elastin, which is reflected in the degeneration of the skin's microrelief, the appearance of wrinkles, and uneven pigmentation (chloasma, unevenness of the facial skin).
[0006] Therefore, protection from UVA and UVB radiation is necessary. Effective photoprotective products should protect against both UVA and UVB radiation.
[0007] To date, a wide range of photoprotective compositions have been proposed to overcome the effects induced by UVA and / or UVB radiation. They generally contain organic and / or inorganic UV filters and function by their own chemical nature and by their own properties of absorbing, reflecting or scattering UV radiation. They generally contain mixtures of oil-soluble organic and / or water-soluble UV filters in combination with metal oxide pigments such as titanium dioxide or zinc oxide.
[0008] In the past, many cosmetic compositions have been proposed to limit skin darkening and improve facial skin tone and evenness.As is well known in the field of sunscreen products, such compositions can be obtained by using UV screening agents, especially UVB screening agents.Some compositions may also contain UVA screening agents.This screening system must contain UVB protection in order to limit and control the new synthesis of melanin, which promotes overall pigmentation, but must also contain UVA protection in order to limit and control the oxidation of existing melanin, which leads to skin darkening.
[0009] However, it is extremely difficult to find a composition containing a specific combination of UV filters that is particularly suitable for photoprotecting the skin and in particular for improving the quality of the skin, both in terms of color and its mechanical elastic properties.
[0010] Advantageously, this improvement is particularly desirable in already pigmented skin, with the aim of not increasing either the melanin pigment load or the structure of the melanin already present in the skin.
[0011] The majority of organic UV filters consist of aromatic compounds that absorb in the wavelength range between 280 and 370 nm. In addition to their ability to filter solar radiation, the desired photoprotective compounds must also have good cosmetic properties, good solubility in common solvents, and good photostability, either alone or in combination with other UV filters. They must also be colorless or at least of a color that is cosmetically acceptable to consumers.
[0012] One of the major known drawbacks of these compositions is that these screening systems are insufficiently effective against UV radiation, particularly long wavelength UVA radiation with wavelengths above 370 nm, for the purpose of controlling photoinduced pigmentation and its progression by systems that screen UV radiation across the entire UV spectrum.
[0013] Among all the compounds recommended for this purpose, a useful family of UV filters consisting of carbon-containing merocyanine derivatives has been proposed.
[0014] In particular, many cosmetic compositions containing UV filters of the merocyanine type are known in the prior art, for example in U.S. Pat. No. 4,195,999, application WO2004 / 006878, document IP COM Journal 4 (4), 16 No. IPCOM000011179D published on March 4, 2004, or application WO2014 / 111570.
[0015] These compounds have very good screening properties in the long-wave UVA radiation range. Moreover, the use of these screening agents in cosmetics is considered safe, exhibiting no acute toxicity and inducing no eye irritation, no skin sensitivity or genotoxicity.
[0016] As a result, due to their numerous beneficial properties, there is a long-standing need in the cosmetic and dermatological fields for the incorporation of merocyanine-type UV filters in various galenic forms, in particular in large amounts, for example of the order of 0.1% to 3% by weight.
[0017] However, these UV filters do not have sufficient solubility in common solvents and, for certain merocyanines, have poor photostability.
[0018] In order to seek other merocyanines with better solubility in common solvents and better photostability, application WO2013 / 011094 proposes merocyanines that contain polar groups composed of hydroxyl and ether functional groups, which show good long-wave UVA shielding efficiency.However, the solubility of these particular merocyanines in oil is still not completely sufficient, and often requires laborious formulation methods.In addition, the large amount of solvent required to dissolve this type of merocyanine may cause cosmetic problems such as stickiness and oiliness during application.
[0019] In addition, many cosmetic galenical forms, such as serums or aqueous gels, lack a fatty phase and therefore this solution does not make it possible to address the problems encountered with such compositions.
[0020] Therefore, it is necessary to be able to incorporate merocyanine-type UV screening agents into aqueous media. In particular, for the benefit of cosmetic quality and performance, this aqueous medium is advantageously a single-phase medium. However, it has been found that this screening agent has very poor solubility in such media. For example, the merocyanine (C) synthesized in the following Example A4 has a water solubility of only about 0.5 g / l at 20°C, which is detrimental to its screening performance.
[0021] As a result, it remains very challenging to use merocyanine-type compounds in the aqueous phase with the lowest possible environmental impact while retaining satisfactory sensory results.
[0022] Disclosure of the Invention The object of the present invention is to solve the above mentioned technical problems.
[0023] In view of the above, it is therefore clear that there remains a need to provide consumers with cosmetic and / or dermatological compositions which comprise UV filters of the merocyanine type in the aqueous phase whilst possessing sufficient cosmetic properties, in particular with regard to sensory properties upon application.
[0024] Thus, there remains a need to improve the water solubility of these merocyanines in photoprotective formulations, especially over long periods of time.
[0025] In particular, there remains a need to increase the water solubility of merocyanine-type screening agents by limiting the use of co-solvents that have sensory effects.
[0026] There remains therefore a need for cosmetic and / or dermatological compositions, in particular photoprotective compositions, which contain a merocyanine-type screening agent in the aqueous phase and which provide a good level of sensory comfort, whether during application to the skin or after drying.
[0027] Finally, there also remains a need to have compositions that meet current consumer demands, especially with regard to the environment.
[0028] The present invention is specifically directed to meeting these needs. [Prior art documents] [Patent documents]
[0029] [Patent Document 1] U.S. Patent No. 4,195,999 [Patent Document 2] WO2004 / 006878 [Patent Document 3] U.S. Patent No. 4,749,643 [Patent Document 4] WO2014 / 111570 [Patent Document 5] WO2013 / 011094 [Patent Document 6] WO2007 / 071582 [Patent Document 7] WO2008 / 155059 [Patent Document 8] U.S. Patent No. 5,624,663 [Patent Document 9] European Patent No. 0669323 [Patent Document 10] U.S. Patent No. 2,463,264 [Patent Document 11] U.S. Patent No. 5,237,071 [Patent Document 12] U.S. Patent No. 5,166,355 [Patent Document 13] British Patent No. 2303549 [Patent Document 14] German Patent No. 19726184 [Patent Document 15] European Patent No. 893119 [Patent Document 16] EP0832642 [Patent Document 17] EP1027883 [Patent Document 18] EP1300137 [Patent Document 19] DE10162844 [Patent Document 20] WO93 / 04665 [Patent Document 21] DE19855649 [Patent Document 22] EP0967200 [Patent Document 23] DE19746654 [Patent Document 24] DE19755649 [Patent Document 25] EP1008586 [Patent Document 26] EP1133980 [Patent Document 27] EP0133981 [Patent Document 28] WO2007 / 071584 [Patent Document 29] WO2009 / 063392 [Patent Document 30] U.S. Patent No. 6,225,467 [Patent Document 31] WO2004 / 085412 [Patent Document 32] WO06 / 035000 [Patent Document 33] WO06 / 034982 [Patent Document 34] WO06 / 034991 [Patent Document 35] WO06 / 035007 [Patent Document 36] WO2006 / 034992 [Patent Document 37] WO2006 / 034985 [Patent Document 38] European Patent No. 0841341 [Patent Document 39] EP0518773 [Patent Document 40] French Patent No. 2977490 [Patent Document 41] WO2013 / 004777 [Patent Document 42] US2014 / 0134120 [Patent Document 43] Patent Publication No. 2003-128788 [Patent Document 44] Patent Publication No. 2000-191789 [Patent Document 45] Patent Publication No. 09-188830 [Patent Document 46] Patent Publication No. 10-158450 [Patent Document 47] JP 10-158541 [Patent Document 48] Patent Publication No. 07-258460 [Patent Document 49] Patent Publication No. 05-017710 [Patent Document 50] EP-A-1086683 [Patent Document 51] U.S. Patent No. 4,077,441 [Patent Document 52] U.S. Patent No. 4,850,517
Non-Patent Literature
[0030]
Non-Patent Literature 1
Non-Patent Literature 2
Non-Patent Literature 3
Non-Patent Literature 4
Non-Patent Literature 5
Non-Patent Literature 6
Non-Patent Literature 7
Non-Patent Literature 8
Non-Patent Literature 9
[0031] Thus, according to a first aspect, the invention relates to a cosmetic or dermatological composition, in particular for making up and / or caring for keratinous materials, comprising at least an aqueous phase, at least one merocyanine of formula (I) and its E / E or E / Z geometric isomeric forms:
[0032] [ka]
[0033] (In the formula, A is -O- or -NH; - R is C1~C 22 Alkyl groups, C2-C 22 Alkenyl groups, C2-C 22 Alkynyl groups, C3-C 22 Cycloalkyl group or C3-C 22a cycloalkenyl group, which can be interrupted by one or more O; at least one hydrotrope selected from nicotinamide, caffeine, salicylates, sodium salt of pyroglutamic acid (sodium PCA), sodium 1,3-benzenedisulfonate, sodium benzoate, sodium 4-pyridinecarboxylate, sodium benzenesulfonate, sodium p-toluenesulfonate (NaPTS), sodium butylmonoglycol sulfate (NaBMGS), 4-aminobenzoic acid HCl, sodium cumenesulfonate, N,N-diethylnicotinamide, N-picolylnicotinamide, N-allylnicotinamide, 2-methacryloyloxyethylphosphorylcholine, resorcinol, pyrogallol, N-picolylacetamide, procaine HCl, proline HCl, pyridine, 3-picolylamine, sodium ibuprofen, sodium xylenesulfonate (SXS), ethyl carbamate, pyridoxal hydrochloride, sodium benzoate, N,N-dimethylacetamide, N-methylacetamide, isoniazid, and mixtures thereof; The present invention relates to a cosmetic or dermatological composition comprising:
[0034] The applicant has surprisingly discovered that it is possible to improve the solubility of these merocyanines in the aqueous phase over long periods and at low temperatures by using certain hydrotropes, this discovery forming the basis of the present invention.
[0035] In particular, the specific hydrotropes used in the compositions according to the invention make it possible to increase the water solubility of these merocyanines and to prevent phase separation of the compositions containing them.
[0036] According to another of its aspects, the present invention also relates to a cosmetic method, in particular a non-therapeutic method, for caring for keratinous materials, in particular keratinous materials of the body and / or face, comprising at least one step of applying to said keratinous materials a composition as defined above.
[0037] Other features, aspects, and advantages of the present invention will become apparent from the following detailed description. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0038] The compositions according to the invention are for cosmetic and / or dermatological use, preferably for cosmetic use.
[0039] The compositions according to the invention are generally suitable for topical application to the skin and therefore generally comprise a physiologically acceptable medium, ie a medium that is compatible with the skin.
[0040] This is preferably a cosmetically acceptable medium, i.e. one that has a pleasant color, odor and feel and does not cause any unacceptable discomfort, i.e. no stinging, tightness or redness, that would cause the user to avoid applying the composition.
[0041] Merocyanine As mentioned above, the composition according to the invention comprises at least one merocyanine of the following formula (I) and its E / E or E / Z geometric isomeric forms:
[0042] [ka]
[0043] (In the formula, A is -O- or -NH; - R is C1~C 22 Alkyl groups, C2-C 22 Alkenyl groups, C2-C 22 Alkynyl groups, C3-C 22 Cycloalkyl group or C3-C 22 cycloalkenyl groups, which can be interrupted by one or more O.
[0044] As shown above, the merocyanine compounds of the present invention may be in their E / E-geometric isomeric form or in their E / Z-geometric isomeric form:
[0045] [ka]
[0046] It could be.
[0047] Preferably, in the compound of formula (1), A is -O- and R is a C1-C aryl group optionally interrupted by one or more O. 22 It is an alkyl.
[0048] Among the compounds of formula (I), more particularly at least one compound selected from the following compounds and also their E / E or E / Z geometric isomeric forms will be used:
[0049] [Table 1]
[0050] According to a more particularly preferred mode of the invention, compounds (A) and / or (C) and mixtures thereof, and even more preferentially compound (C) in its E / E and / or E / Z geometric configuration, will be used.
[0051] Thus, preferably, the composition according to the invention comprises 2-ethoxyethyl (2Z)-cyano{3-[(3-methoxypropyl)amino]cyclohex-2-en-1-ylidene}ethanoate (C), also known as methoxypropylaminocyclohexenylideneethoxyethyl cyanoacetate, in its E / E and / or E / Z geometric configuration.
[0052] The E / Z configuration has the following structure:
[0053] [ka]
[0054] has.
[0055] The E / E form has the following structure:
[0056] [ka]
[0057] has.
[0058] According to a preferred embodiment, the composition according to the invention comprises at least one merocyanine of formula (I) as defined above, in a content ranging from 0.1% to 25% by weight, preferentially from 0.2% to 20% by weight, more preferentially from 0.5% to 10% by weight and even better still from 1% to 5% by weight relative to the total weight of the composition.
[0059] In general, compounds of the merocyanine type can be prepared according to known methods, for example as described in J. Org. Chem. USSR (English Translation) 26(8), p.1562f (1990), J. Heterocycl.Chem.33(3), pp.763-766 (1996), Khimiya Geterotsiklicheskikh Soedinenii 11, pp.1537-1543 (1984), Khimiya Geterotsiklicheskikh Soedinenii 3, pp.397-404 (1982), Chem. Heterocycl. Comp. (English Translation), 24(8), pp.914-919 (1988), and Synthetic Communications, Vol. 33, No. 3, 2003, pp.367-371.
[0060] With regard to the compounds according to formula (I), which are more particularly considered according to the present invention and have the particular feature of having a carbocyclic ring containing 6 carbon atoms, they may be prepared according to the protocols described in patent application WO2007 / 071582, entitled "Process for producing 3-amino-2-cyclohexan-1-ylidene compounds", IP.com Journal (2009), 9(5A), 29-30 IPCOM000182396D, and in U.S. Pat. No. 4,749,643, column 13, line 66 to column 14, line 57, and in the references cited in this connection.
[0061] Specifically, the compounds of formula (I) from Table 1 above can be synthesized according to the synthetic scheme described in the publication by B. Winkler et al., Tetrahedron Letters, 55 (2014) 1749-1751, entitled "A cyclic merocyanine UV-A absorber: mechanism of formation and crystal structure", which is shown below for the compounds of formula (I).
[0062] [ka]
[0063] For compounds (C) from Table 1, the following synthesis scheme is preferred:
[0064] [ka]
[0065] The synthesis illustrated by this scheme is specifically detailed in Example A4 below.
[0066] Hydrotropes As previously mentioned, the compositions according to the present invention may contain nicotinamide, caffeine, salicylate, sodium salt of pyroglutamic acid (sodium PCA), sodium 1,3-benzenedisulfonate, sodium benzoate, sodium 4-pyridinecarboxylate, sodium benzenesulfonate, sodium p-toluenesulfonate (NaPTS), sodium butyl monoglycol sulfate (NaBMGS), 4-aminobenzoic acid HCl, sodium cumenesulfonate, N,N-diethylnicotinamide, N-picolylnicotinamide. The hydrotrope comprises at least one hydrotrope selected from the group consisting of acetamide, N-allylnicotinamide, 2-methacryloyloxyethyl phosphorylcholine, resorcinol, pyrogallol, N-picolylacetamide, procaine HCl, proline HCl, pyridine, 3-picolylamine, sodium ibuprofen, sodium xylene sulfonate (SXS), ethyl carbamate, pyridoxal hydrochloride, sodium benzoate, N,N-dimethylacetamide, N-methylacetamide, isoniazid, and mixtures thereof.
[0067] According to a preferred embodiment, the composition according to the invention comprises at least one hydrotrope selected from nicotinamide, caffeine, and mixtures thereof. In particular, such compositions include salicylates, sodium salt of pyroglutamic acid (sodium PCA), sodium 1,3-benzenedisulfonate, sodium benzoate, sodium 4-pyridinecarboxylate, sodium benzenesulfonate, sodium p-toluenesulfonate (NaPTS), sodium butylmonoglycol sulfate (NaBMGS), 4-aminobenzoic acid HCl, sodium cumenesulfonate, N,N-diethylnicotinamide, N-picolylnicotinamide, N-allylnicotinamide, 2-methacryloyl nicotinamide, 2-methyl-2-propanediol, 2-methyl-1, ... The composition may further comprise at least one additional hydrotrope, preferably at least one salicylate, selected from prolyloxyethyl phosphorylcholine, resorcinol, pyrogallol, N-picolylacetamide, procaine HCl, proline HCl, pyridine, 3-picolylamine, ibuprofen sodium, sodium xylene sulfonate (SXS), ethyl carbamate, pyridoxal hydrochloride, sodium benzoate, N,N-dimethylacetamide, N-methylacetamide, isoniazid, and mixtures thereof.
[0068] According to a variant embodiment, the composition according to the invention comprises at least one hydrotrope chosen from nicotinamide, caffeine and mixtures thereof, combined with at least one salicylate.
[0069] The salicylate may specifically be selected from sodium salicylate, lysine salicylate, arginine salicylate, magnesium salicylate, and mixtures thereof.
[0070] Preferably, the salicylate is sodium salicylate.
[0071] According to a preferred embodiment, the composition according to the invention comprises at least nicotinamide as hydrotrope.
[0072] According to one particular embodiment, the composition according to the invention comprises nicotinamide and sodium salicylate.
[0073] The hydrotrope is present in the composition according to the present invention in an amount effective to dissolve the merocyanine of formula (I) above in water.
[0074] The content of the hydrotrope according to the invention present in the composition according to the invention may range from 0.1% to 20% by weight, in particular from 0.1% to 10% by weight, preferably from 0.5% to 10% by weight, in particular from 0.5% to 3% by weight, relative to the total weight of the composition.
[0075] Specifically, the merocyanine of formula (I) according to the invention / hydrotrope mass ratio of the composition according to the invention ranges from 0.01 to 8, preferably from 0.02 to 5, specifically from 0.05 to 3, more specifically from 0.1 to 1.5.
[0076] According to one particular embodiment, the composition according to the invention comprises at least two different hydrotropes chosen from nicotinamide, caffeine and sodium salicylate, the merocyanine of formula (I) / hydrotrope mass ratio of the composition according to the invention ranging from 0.01 to 5, preferably from 0.02 to 3, in particular from 0.05 to 2 and more preferentially from 0.1 to 1.5.
[0077] According to one particular embodiment, the composition according to the invention comprises two different hydrotropes, preferably nicotinamide and caffeine, the mass ratio between these two hydrotropes ranging from 0.2 to 5, in particular from 0.5 to 3 and more preferentially from 0.8 to 1.2.
[0078] aqueous phase The composition according to the invention comprises an aqueous phase and optionally an oily phase.
[0079] The aqueous phase comprises water and optionally a water-soluble organic solvent, and is preferably a single phase.
[0080] According to a preferred embodiment, the composition according to the invention has a water content of between 10% and 98% by weight, preferably between 25% and 90% by weight and more preferentially between 35% and 85% by weight relative to the total weight of the composition.
[0081] According to the present invention, the term "water-soluble organic solvent" means a compound that is liquid at room temperature and is water-miscible (miscible with more than 50% by weight of water at 25° C. and atmospheric pressure).
[0082] The water-soluble solvents that can be used in the compositions of the present invention may also be volatile. Specifically, to obtain a composition having a BC3 content greater than 0.9%, a water-soluble co-solvent will be used in addition to the hydrotrope.
[0083] Among the water-soluble solvents which can be used in the composition according to the invention, particular mention may be made of lower monoalcohols containing 1 to 5 carbon atoms, such as ethanol and isopropanol, polyols and also alkylene carbonates.
[0084] According to one preferred embodiment, the composition according to the invention also comprises at least one alcohol, in particular a monoalcohol, preferably ethanol.
[0085] Preferably, in the composition according to the invention, the alcohol may be present in a content ranging from 0.5% to 30% by weight, better still from 2.0% to 25% by weight, preferably from 3.0% to 15% by weight, relative to the total weight of said composition.
[0086] According to a variant embodiment, the aqueous phase of the composition according to the invention comprises at least one C2 to C 32 It may include a polyol.
[0087] Within the meaning of the present invention, the term "polyol" should be understood to mean any organic molecule that contains at least two free hydroxyl groups.
[0088] Preferably, the polyol according to the invention is in liquid form at room temperature.
[0089] Polyols suitable for use in the present invention can be linear, branched, or cyclic, saturated or unsaturated alkyl-type compounds carrying at least two -OH functional groups in the alkyl chain, specifically at least three -OH functional groups, more specifically at least four -OH functional groups.
[0090] Polyols that are suitable for formulating the composition according to the invention are in particular those containing in particular from 2 to 32 carbon atoms, preferably from 3 to 16 carbon atoms.
[0091] The polyol may be selected, for example, from ethylene glycol, pentaerythritol, trimethylolpropane, propylene glycol, 1,3-propanediol, butylene glycol, isoprene glycol, pentylene glycol, hexylene glycol, C3 and C4 ketones and C2-C4 aldehydes, caprylyl glycol, glycerol, polyglycerols, such as glycerol oligomers, for example diglycerol, polyethylene glycol, and mixtures thereof.
[0092] According to a preferred embodiment of the invention, the polyol is selected from ethylene glycol, pentaerythritol, trimethylolpropane, pentylene glycol, propylene glycol, dipropylene glycol (DPG), caprylyl glycol, glycerol, polyglycerol, polyethylene glycol (PEG), and mixtures thereof.
[0093] According to one particular embodiment, the composition of the invention may comprise at least one polyol, in particular one chosen from glycerol, caprylyl glycol, propylene glycol, pentylene glycol, dipropylene glycol (DPG), PEG-8, and mixtures thereof.
[0094] According to a preferred embodiment, the composition of the invention may comprise at least one polyol, in particular one chosen from propylene glycol, pentylene glycol, dipropylene glycol (DPG), and mixtures thereof.
[0095] Preferably, the composition of the present invention may contain at least dipropylene glycol (DPG) as the polyol.
[0096] If present, the polyol is preferably present in the composition according to the invention in a content ranging from 0.5% to 40% by weight, better still from 3% to 30% by weight and preferably from 5% to 25% by weight relative to the total weight of said composition.
[0097] According to another particular embodiment, the composition of the invention may comprise at least one alkylene carbonate, in particular one selected from those of formula (II) below:
[0098] [ka]
[0099] (In the formula, R' represents a hydrogen atom, a linear or branched C1-C6 alkyl group, or a linear or branched C1-C4 hydroxyalkyl group; R″ represents a hydrogen atom, a linear or branched C1-C6 alkyl group, or a linear or branched C1-C4 hydroxyalkyl group; m is 1, 2, or 3.
[0100] Preferably, the R' group represents a hydrogen atom, a linear or branched C1-C4 alkyl group, or a linear or branched C1-C2 hydroxyalkyl group.
[0101] R'' represents a hydrogen atom, a linear or branched C1 to C2 alkyl group, or a linear or branched C1 to C2 hydroxyalkyl group.
[0102] Preferably, m is 1.
[0103] Particularly useful examples of alkylene carbonates include compounds in which the R' group represents a hydrogen atom (corresponding to ethylene carbonate), a methyl group (corresponding to propylene carbonate), an ethyl group (corresponding to 1,2-butylene carbonate) or a hydroxymethyl group (R'=-CHOH, corresponding to glycerol carbonate).
[0104] Preferably, the alkylene carbonate used is propylene carbonate.
[0105] The alkyl or alkylene carbonate may be present in the composition according to the invention in a concentration ranging preferably from 0.1% to 98% by weight, in particular from 0.5% to 50% by weight, more preferentially from 1% to 20% by weight, even more particularly from 1% to 10% by weight and in particular from 1% to 6% by weight, relative to the total weight of the composition.
[0106] As will become apparent from the examples presented below, when one of the above-mentioned organic solvents is used together with at least one hydrotrope, an increase in the solubility of the merocyanine of formula (I) can be observed, which is particularly advantageous for dissolving large amounts of the merocyanine in an aqueous medium.
[0107] Thus, according to one variant embodiment, the composition according to the invention may further comprise at least one hydrotrope, at least one organic solvent, in particular chosen from alcohols, in particular polyols, and an alkylene carbonate.
[0108] In addition to the above-mentioned solvents, the composition according to the invention also comprises: ketones which are liquid at room temperature, such as methyl ethyl ketone, methyl isobutyl ketone, diisobutyl ketone, isophorone, cyclohexanone or acetone; cyclic ethers, for example gamma-butyrolactone, - short chain esters (having a total of 3 to 8 carbon atoms), such as ethyl acetate, butyl acetate, methyl acetate, propyl acetate, isopropyl acetate, isopentyl acetate, methoxypropyl acetate, or butyl lactate; ethers which are liquid at room temperature, such as diethyl ether, dimethyl ether or dichlorodiethyl ether; alkanes which are liquid at room temperature, such as decane, heptane, dodecane or cyclohexane; alkyl sulfoxides, for example dimethyl sulfoxide, aldehydes which are liquid at room temperature, such as benzaldehyde or acetaldehyde, - 3-ethyl ethoxypropionate, acetals, for example methylal, and - A mixture of these The solvent may include at least one organic solvent selected from the group consisting of:
[0109] The aqueous phase may also include any water-soluble or water-dispersible compound that is compatible with the aqueous phase, such as stabilizers, gelling agents, film-forming polymers, thickeners, surfactants, and mixtures thereof.
[0110] Preferably, the aqueous phase is present in the composition according to the invention in a content ranging from 30% to 100% by weight, preferably from 35% to 99.5% by weight and more preferentially from 45% to 99% by weight relative to the total weight of said composition.
[0111] fat phase As mentioned above, the composition according to the invention may comprise at least one fatty phase.
[0112] For the purposes of the present invention, the term "fatty phase" means a phase comprising at least one oil and all the fat-soluble and lipophilic components and fatty substances used in the formulation of the composition of the invention.
[0113] In particular, the composition according to the invention may comprise a fatty phase ranging from 0.5% to 80% by weight, preferably from 1% to 40% by weight and more preferentially from 3% to 20% by weight relative to the total weight of the composition.
[0114] The fatty phase of the composition according to the invention may comprise an oil, a wax, a pasty compound and / or a silicone compound, and preferably at least one oil, and in particular a cosmetic oil.
[0115] oil The term "oil" refers to a water-immiscible, non-aqueous compound that is liquid at room temperature (20° C.) and atmospheric pressure (760 mmHg).
[0116] The fatty phase that is suitable for the preparation of the compositions according to the invention, in particular the cosmetic compositions, may comprise a hydrocarbon oil, a silicone oil, a fluoro or non-fluoro oil, or a mixture thereof.
[0117] The oil may be volatile or non-volatile.
[0118] The oils may be of animal, vegetable, mineral or synthetic origin.
[0119] The fatty phase may comprise, in addition to the merocyanine shielding agent and optionally a lipophilic additional shielding agent, at least one volatile or non-volatile hydrocarbon oil and / or one volatile and / or non-volatile silicone oil and / or one volatile and / or non-volatile fluoro oil.
[0120] For the purposes of the present invention, the term "hydrocarbon oil" is intended to mean an oil that contains mainly hydrogen and carbon atoms.
[0121] The term "silicone oil" is intended to mean an oil containing at least one silicon atom and in particular at least one Si-O group.
[0122] The term "fluoro oil" means an oil containing at least one fluorine atom.
[0123] The oil may optionally contain oxygen, nitrogen, sulfur, and / or phosphorus atoms, for example in the form of hydroxyl or acid groups.
[0124] Volatile Oil For the purposes of the present invention, the term "volatile oil" means any oil that is capable of evaporating on contact with the skin in less than one hour at room temperature and atmospheric pressure. Volatile oils are liquid at room temperature and have a non-zero vapor pressure, in particular between 0.13 Pa and 40,000 Pa (10 -3 The cosmetic compound is a volatile cosmetic compound having a vapor pressure in the range of 1.3 Pa to 13000 Pa (0.01 to 100 mmHg), specifically in the range of 1.3 Pa to 1300 Pa (0.01 to 10 mmHg), more specifically in the range of 1.3 Pa to 1300 Pa (0.01 to 10 mmHg).
[0125] The volatile oil may be a hydrocarbon oil or a silicone oil.
[0126] Among volatile hydrocarbon oils containing 8 to 16 carbon atoms, branched C8-C 16 Alkanes, e.g. C8-C 16 Isoalkanes (also known as isoparaffins), isododecane, isodecane, isohexadecane, for example the oils sold under the trade names Isopar or Permethyl, branched C8-C 16 Particular mention may be made of esters such as isohexyl neopentanoate, as well as mixtures thereof.
[0127] Also included are volatile linear alkanes containing 8 to 16 carbon atoms, in particular 10 to 15 carbon atoms, more particularly 11 to 13 carbon atoms, such as n-dodecane (C 2 ), sold by the company Sasol under the references Parafol 12-97 and Parafol 14-97, respectively. 12 ) and n-tetradecane (C 14), as well as mixtures thereof, undecane-tridecane mixtures, and n-undecane (C 11 ) and n-tridecane (C 13 ) as well as mixtures thereof.
[0128] Volatile silicone oils that may be mentioned include volatile linear silicone oils such as hexamethyldisiloxane, octamethyltrisiloxane, decamethyltetrasiloxane, tetradecamethylhexasiloxane, hexadecamethylheptasiloxane, and dodecamethylpentasiloxane.
[0129] Volatile cyclic silicone oils that may be mentioned include hexamethylcyclotrisiloxane, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, cyclohexasiloxane and dodecamethylcyclohexasiloxane, and in particular cyclohexasiloxane.
[0130] Volatile fluoro oils such as nonafluoromethoxybutane, decafluoropentane, tetradecafluorohexane, dodecafluoropentane, and mixtures thereof may also be used.
[0131] Fixed oil The term "non-volatile" refers to a substance whose vapor pressure at room temperature and atmospheric pressure is not zero but is greater than 10 -3 It is intended to mean an oil having a viscosity of less than mmHg (0.13 Pa).
[0132] The non-volatile oils may in particular be chosen from non-volatile hydrocarbon oils, fluoro oils and / or silicone oils.
[0133] Non-volatile hydrocarbon oils that may be mentioned in particular are: - hydrocarbon oils of animal origin, - linear or branched hydrocarbons of mineral or synthetic origin, for example vaseline, polydecene, hydrogenated polyisobutenes such as Parleam, squalane, and mixtures thereof; - non-volatile alkanes, preferably those having a viscosity of less than 20 mPa.s at 20°C, measured using a Rheomat Rm100® viscometer from Lamy Rheology. The term "non-volatile alkanes" means hydrocarbon cosmetic oils which are liquid at room temperature and in particular have a vapour pressure of less than 0.01 kPa at 20°C, according to the definition of Volatile Organic Compounds (VOC) in article 2 of the European Council Directive 1999 / 13 / Ec of 11 March 1992: "Any organic compound having, at a temperature of 293.15 K, a vapour pressure of 0.01 kPa or more". In particular, non-volatile alkanes are mixtures of alkanes containing 10 to 30 carbon atoms, in particular 12 to 26 carbon atoms, more particularly 15 to 19 carbon atoms, preferably 15 to 19 carbon atoms, such as, for example, the products sold under the references Emogreen L19 and Emosmart L19 by the company SEPPIC, - hydrocarbon oils of vegetable origin, such as glyceride triesters, which are generally triesters of fatty acids and glycerol, the fatty acids of which may have various chain lengths of 4 to 24 carbon atoms, which chains may be saturated or unsaturated, linear or branched, these oils being in particular wheat germ oil, sunflower oil, grape seed oil, sesame oil, corn oil, apricot oil, castor oil, shea oil, avocado oil, olive oil, soybean oil, oils, sweet almond oil, palm oil, rapeseed oil, cottonseed oil, hazelnut oil, macadamia oil, jojoba oil, alfalfa oil, poppy oil, pumpkin oil, sesame oil, mallow oil, black currant oil, evening primrose oil, millet oil, barley oil, quinoa oil, rye oil, safflower oil, kukui nut oil, passionflower oil and rose moschata oil, or else caprylic / capric triglycerides, such as those sold by the company Stearinerie Dubois or under the names Miglyol 810, 812 and 818 by the company Dynamit Nobel, - synthetic ethers containing 10 to 40 carbon atoms, such as dicapryl ether, synthetic esters, such as oils of formula R1COOR2, where R1 represents a linear or branched fatty acid residue containing 1 to 40 carbon atoms and R2 represents a hydrocarbon chain, especially branched, containing 1 to 40 carbon atoms, with the proviso that R1+R2 is greater than or equal to 10, such as Purcellin oil (cetostearyl octanoate), isopropyl myristate, isopropyl palmitate, alkyl benzoates having between 12 and 15 carbon atoms, such as the products sold under the trade names Finsolv TN or Witconol TN by the company Witco or Tegosoft TN by the company Evonik Goldschmidt, 2-ethylphenyl benzoate, such as the products sold under the name X-Tend by the company ISP; 226, isopropyl lanolate, hexyl laurate, diisopropyl adipate, isononyl isononanoate, oleyl erucate, 2-ethylhexyl palmitate, isostearyl isostearate, diisopropyl sebacate, for example the products sold under the name Dub Dis by the company Stearinerie Dubois, octanoic, decanoic or ricinoleic esters of alcohols or polyalcohols, for example propylene glycol dioctanoate; hydroxylated esters, for example isostearyl lactate, diisostearyl maleate; as well as pentaerythritol esters; citrate esters, for example C3-C 22 Esters of tricarboxylic acids and C1-C6 alcohols, such as the INCI name triethyl citrate, for example that sold under the name Citrofol AI Extra by the company Jungbunzlauer; tartrates, for example linear dialkyl tartrates having 12 and 13 carbon atoms, for example that sold under the name Cosmacol ETI by the company Enichem Augusta Industriale, and also linear dialkyl tartrates having between 14 and 15 carbon atoms, for example that sold under the name Cosmacol ETL by the same company, and acetates, aliphatic amides, such as isopropyl N-lauroylsarcosinate, for example the product sold under the trade name Eldew SL205 by the company Ajinomoto; - polyol esters and pentaerythritol esters, for example dipentaerythritol tetrahydroxystearic acid / tetraisostearic acid, aliphatic alcohols which are liquid at room temperature and have a branched and / or unsaturated carbon-based chain containing from 12 to 26 carbon atoms, such as octyldodecanol, isostearyl alcohol, oleyl alcohol, 2-hexyldecanol, 2-butyloctanol or 2-undecylpentadecanol; - C 12 ~C 22 Higher fatty acids, such as oleic acid, linoleic acid, linolenic acid, and mixtures thereof; carbonates, such as dicaprylyl carbonate, for example the product sold under the name Cetiol CC by the company Cognis; non-phenyl silicone oils, such as caprylyl methicone, phenyl silicone oils, such as phenyl trimethicone, phenyl dimethicone, phenyl trimethylsiloxy diphenyl siloxane, diphenyl dimethicone, diphenyl methyl diphenyl trisiloxane and 2-phenylethyl trimethyl siloxy silicate, dimethicone or phenyl trimethicone having a viscosity of less than or equal to 100 cSt, trimethyl pentaphenyl trisiloxane and mixtures thereof; and even mixtures of these various oils. Examples include:
[0134] Other fatty substances The fatty phase according to the invention may further comprise other fatty substances mixed with the oil or dissolved in the oil.
[0135] Other fatty substances which may be present in the oily phase are, for example: - fatty acids containing 8 to 30 carbon atoms, such as stearic acid, lauric acid, palmitic acid and oleic acid; waxes other than glyceryl trihydroxystearate, such as lanolin, beeswax, carnauba wax or candelilla wax, paraffin wax, lignite wax or microcrystalline wax, ceresin or ozokerite, or synthetic waxes, such as polyethylene wax or Fischer-Tropsch wax; silicone resins, such as trifluoromethyl (C1-C4) alkyl dimethicones and trifluoropropyl dimethicones; silicone elastomers, such as the products sold under the name KSG by the company Shin-Etsu, the products sold under the name Trefil or BY29 by the company Dow Corning or the products sold under the name Gransil by the company Grant Industries; - a gum selected from silicone gums (dimethiconol), pasty compounds, such as polymeric or non-polymeric silicone compounds, esters of oligomeric glycerol, arachidyl propionate, fatty acid triglycerides and derivatives thereof; - and mixtures thereof It is.
[0136] As fatty substance, the composition according to the invention may comprise at least one fatty alcohol wax, which may be chosen from lauric or lauryl alcohol, myristic or myristyl alcohol, cetyl alcohol, stearyl alcohol, arachidyl alcohol, behenyl alcohol, lignoceryl alcohol, ceryl alcohol, montanyl alcohol, myricyl alcohol, and mixtures thereof.
[0137] As fatty substance, the composition according to the invention may comprise at least one butter, in particular a vegetable butter.
[0138] The vegetable butter suitable for use in the present invention is preferably selected from the group comprising avocado butter, cocoa butter, shea butter, kokum butter, mango butter, murumuru butter, coconut butter, apricot kernel butter, sal butter and urucum butter, and mixtures thereof, in particular shea butter.
[0139] These fatty substances may be selected in various ways by those skilled in the art in order to prepare a composition having the desired properties, for example in terms of consistency or texture.
[0140] According to a preferred embodiment, the composition according to the invention contains at least one non-volatile oil, preferably at least one non-volatile hydrocarbon oil, in particular chosen from linear or branched hydrocarbons of mineral or synthetic origin, non-volatile alkanes, hydrocarbon oils of vegetable origin, synthetic esters, fatty amides, carbonates, and also mixtures of these various oils.
[0141] Specifically, such non-volatile hydrocarbon oils may be present in the composition according to the present invention in a content ranging from 2.0% by mass to 20.0% by mass, preferably from 2.0% by mass to 15.0% by mass, relative to the total mass of the composition.
[0142] According to a preferred embodiment, the composition according to the invention comprises C3-C alkyl esters with the INCI names squalane, a mixture of alkanes containing 15 to 19 carbon atoms, caprylic / capric triglyceride, alkyl benzoates having between 12 and 15 carbon atoms, diisopropyl adipate, 2-ethylhexyl palmitate, diisopropyl sebacate, citric acid esters, triethyl citrate. 22 It contains at least one oil selected from esters of tricarboxylic acids and C1-C6 alcohols, isopropyl N-lauroyl sarcosinate, dicaprylyl carbonate, and mixtures thereof.
[0143] Preferably, the composition according to the invention comprises less than 2.0% by weight of silicone oil, in particular less than 1.0% by weight of silicone oil, preferably less than 0.5% by weight of silicone oil, relative to the total weight of the composition, and more preferentially no silicone oil.
[0144] Preferably, the composition according to the invention comprises a fatty phase containing at least one fatty substance.
[0145] According to a preferred embodiment, the composition according to the invention comprises at least one non-volatile hydrocarbon oil, preferably at least one non-volatile ester oil.
[0146] According to a preferred embodiment, the composition according to the invention further comprises at least one solid fatty substance, in particular a fatty acid containing from 8 to 30 carbon atoms, and more preferentially stearic acid.
[0147] Additional UV protection The composition according to the invention may contain, in addition to the merocyanine of formula (I) described above, at least one additional UV filter.
[0148] Specifically, the composition according to the present invention may contain, in addition to the merocyanine of formula (I) described above, at least one compound for blocking UVA and / or UVB rays.
[0149] The composition according to the invention may therefore also contain one or more additional UV filters chosen from hydrophilic, lipophilic or insoluble organic UV filters and / or one or more mineral pigments, and it is preferentially composed of at least one hydrophilic, lipophilic or insoluble organic UV filter.
[0150] The term "hydrophilic UV filter" is intended to mean any cosmetic or dermatological organic or inorganic compound for filtering UV radiation that can be completely dissolved in molecular form in a liquid aqueous phase or that can otherwise be dissolved in colloidal form (e.g. in micellar form) in a liquid aqueous phase.
[0151] The term "lipophilic screening agent" is intended to mean any cosmetic or dermatological organic or inorganic compound for screening UV radiation, which can be completely dissolved in molecular form in the liquid fatty phase or which can be dissolved in colloidal form (for example in micellar form) in the liquid fatty phase.
[0152] The term "insoluble organic UV filter" is intended to mean any cosmetic or dermatological organic or inorganic compound for screening UV radiation, which has a solubility of less than 0.5% by weight in water and less than 0.5% by weight in most organic solvents, such as liquid paraffin, fatty alcohol benzoates, and fatty acid triglycerides, such as Miglyol 812® sold by Dynamit Nobel. This solubility, measured at 70°C, is defined as the amount of product in solution in the solvent that is in equilibrium with the excess solid in the suspension after returning to room temperature. It can be easily evaluated in the laboratory.
[0153] Additional organic UV filters are in particular cinnamic acid compounds; anthranilic acid compounds; salicylic acid compounds; dibenzoylmethane compounds; benzylidene camphor compounds; benzophenone compounds; β,β-diphenylacrylate compounds; triazine compounds; benzotriazole compounds; benzalmalonate compounds, in particular those listed in U.S. Pat. No. 5,624,663; benzimidazole derivatives; imidazoline compounds; bis-benzoazolyl compounds, such as those described in European Patent No. 0,669,323 and U.S. Pat. No. 2,463,264; p-aminobenzoic acid (PABA) compounds; methylene bis(hydroxyphenylbenzotriazole) compounds, such as those described in U.S. Pat. Nos. 5,237,071, 5,166,355 and British Patent No. 230,354. 9, DE 19726184 and EP 893119; benzoxazole compounds, such as those described in patent applications EP 0832642, EP 1027883, EP 1300137 and DE 10162844; shielding polymers and shielding silicones, such as those described in particular in patent application WO 93 / 04665; dimers derived from α-alkylstyrenes, such as those described in patent application DE 19855649; 4,4-diarylbutadiene compounds, such as those described in patent application EP 0967200, DE 19746654, DE 19755649, EP 1008586, EP 1133980 and EP 0133981; and mixtures thereof.
[0154] Examples of organic photoprotective agents include those shown below by their INCI names. Cinnamates: - ethylhexyl methoxycinnamate, in particular that sold under the trade name Parsol MCX by DSM Nutritional Products, - isopropyl methoxycinnamate, isoamyl p-methoxycinnamate, sold under the trade name Neo Heliopan E 1000® by the company Symrise; - DEA Methoxycinnamate, - diisopropyl methylcinnamate, - Glyceryl dimethoxycinnamate ethylhexanoate. Dibenzoylmethane compounds: - butyl methoxydibenzoylmethane, in particular that sold under the trade name Parsol 1789 by DSM Nutritional Products, - Isopropyldibenzoylmethane. Para-aminobenzoic acid compounds: - PABA, - Ethyl PABA, - Ethyl Dihydroxypropyl PABA, - ethylhexyl dimethyl PABA, in particular that sold under the name Escalol 507® by the company ISP; - Glyceryl PABA, - PEG-25 PABA, sold under the name Uvinul P25® by the company BASF. Salicylic Acid Compounds: - Homosalate, sold under the name Eusolex HMS by Rona / EM Industries, - ethylhexyl salicylate, sold under the name Neo Heliopan OS by the company Symrise; - dipropylene glycol salicylate, sold under the name Dipsal by the company Scher; - TEA salicylate, sold under the name Neo Heliopan TS® by the company Symrise. β,β-Diphenyl acrylate compounds: octocrylene, in particular that sold under the trade name Uvinul N 539® by the company BASF; Etocrilene, in particular that sold under the trade name Uvinul N 35® by the company BASF. Benzophenone compounds: Benzophenone-1, sold under the trade name Uvinul 400® by the company BASF; Benzophenone-2, sold under the trade name Uvinul D 50® by the company BASF; - benzophenone-3 or oxybenzone, sold under the trade name Uvinul M 40® by the company BASF; Benzophenone-4, sold under the trade name Uvinul MS 40® by the company BASF; - Benzophenone-5, - benzophenone-6, sold under the trade name Helisorb 11® by the company Norquay; - benzophenone-8, sold under the trade name Spectra-Sorb UV-24® by American Cyanamid; Benzophenone-9, sold under the trade name Uvinul DS 49® by the company BASF; - Benzophenone-12, n-Hexyl 2-(4-diethylamino-2-hydroxybenzoyl)benzoate, sold by BASF under the trade name Uvinul A Plus® or, in a mixture with octyl methoxycinnamate, under the trade name Uvinul A Plus B®; - 1,1'-(1,4-piperazinediyl)bis[1-[2-[4-(diethylamino)-2-hydroxybenzoyl]phenyl]-methanone] (CAS 919803-06-8), described in application WO 2007 / 071584; this compound is advantageously used in micronized form (average particle size between 0.02 and 2 μm) and can be obtained, in particular in the form of an aqueous dispersion, for example according to the micronization methods described in applications GB 2 303 549 and EP 0 893 119. Benzylidene camphor compounds: - 3-benzylidene camphor, manufactured by the company Chimex under the name Mexoryl SD®; 4-methylbenzylidene camphor, sold under the name Eusolex 6300® by the company Merck; benzylidene camphorsulfonic acid, manufactured by the company Chimex under the name Mexoryl SL®; - benzalkonium camphormethosulfate, manufactured by the company Chimex under the name Mexoryl SO®; - terephthalylidene dicamphorsulfonic acid, manufactured by the company Chimex under the name Mexoryl SX®; - Polyacrylamidomethylbenzylidene camphor, manufactured by the company Chimex under the name Mexoryl SW®. Phenylbenzimidazole compounds: - phenylbenzimidazole sulfonic acids, in particular those sold under the trade name Eusolex 232® by the company Merck. Bis-benzoazolyl compounds: - disodium phenyldibenzimidazole tetrasulfonate, sold under the trade name Neo Heliopan AP® by the company Haarmann and Reimer. Phenylbenzotriazole compounds: - Drometrizole trisiloxane, sold under the name Silatrizole® by the company Rhodia Chimie. Methylene bis(hydroxyphenylbenzotriazole) compounds: methylenebis-benzotriazolyltetramethylbutylphenol, in particular in solid form, for example the product sold under the trade name Mixxim BB / 100® by Fairmount Chemical Company, or finely divided particles having an average particle size ranging from 0.01 to 5 μm, more preferentially from 0.01 to 2 μm and more particularly from 0.020 to 2 μm, with structure C n H 2n+1 O(CH 10 O5) xH, where n is an integer from 8 to 16, and x is (CH 10 in the form of an aqueous dispersion with at least one alkyl polyglycoside surfactant having an average degree of polymerization of the glycerol unit (C8-C05) ranging from 1.4 to 1.6, for example as described in patent GB 2303549 and in particular as sold under the trade name Tinosorb M® by the company BASF, or at least one polyglyceryl mono (C8-C05) surfactant having a degree of glycerol polymerization of at least 5. 20 ) in the form of an aqueous dispersion of micronized particles with an average particle size in the range of 0.02 to 2 μm, more preferentially 0.01 to 1.5 μm and more particularly 0.02 to 1 μm, in the presence of alkyl esters, for example the aqueous dispersions described in application WO 2009 / 063392. Triazine compounds: - 3,3'-(1,4-phenylene)bis(5,6-diphenyl-1,2,4-triazine), which has the INCI name Phenylenebis-diphenyltriazine and the following chemical structure:
[0155] [ka]
[0156] having - bis-ethylhexyloxyphenol methoxyphenyl triazine, sold under the trade name Tinosorb S® by the company BASF; ethylhexyl triazone, in particular that sold under the trade name Uvinul T 150® by the company BASF; - diethylhexylbutamide triazone, sold under the trade name Uvasorb HEB® by the company Sigma 3V; - 2,4,6-tris(dineopentyl 4'-aminobenzalmalonate)-s-triazine, - 2,4,6-tris(diisobutyl 4'-aminobenzalmalonate)-s-triazine, - 2,4-bis(n-butyl 4'-aminobenzoate)-6-(aminopropyltrisiloxane)-s-triazine, - 2,4-bis(dineopentyl 4'-aminobenzalmalonate)-6-(n-butyl 4'-aminobenzoate)-s-triazine, - symmetric triazine shielding agents substituted with naphthalenyl or polyphenyl groups, US Pat. No. 6,225,467, application WO2004 / 085412 (see compounds 6 and 9), or the publication "Symmetrical Triazine Derivatives", IP.COM IPCOM000031257 Journal, INC., West Henrietta, NY, US (September 20, 2004), in particular 2,4,6-tris(diphenyl)triazine and 2,4,6-tris(terphenyl)triazine, which are also mentioned in applications WO 06 / 035000, WO 06 / 034982, WO 06 / 034991, WO 06 / 035007, WO 2006 / 034992 and WO 2006 / 034985, which compounds are advantageously used in micronized form (average particle size of 0.02 to 3 μm), which can be obtained, in particular in the form of an aqueous dispersion, for example according to the micronization methods described in applications GB-A-2303549 and EP-A-893119, - silicone triazines substituted with two aminobenzoate groups, such as those described in EP 0 841 341, in particular 2,4-bis(n-butyl 4'-aminobenzalmalonate)-6-[(3-{1,3,3,3-tetramethyl-1-[(trimethylsilyl)oxy]disiloxanyl}propyl)amino]-s-triazine. Anthranilic Acid Compounds: - Menthyl anthranilate, sold under the trade name Neo Heliopan MA® by the company Symrise. Imidazoline compounds: - Ethylhexyl dimethoxybenzylidene dioxoimidazoline propionate. Benzalmalonate compounds: - polyorganosiloxanes containing benzalmalonate functional groups, such as Polysilicone-15, sold under the trade name Parsol SLX® by the company Hoffmann-LaRoche. 4,4-Diarylbutadiene Compounds: - 1,1-dicarboxy(2,2'-dimethylpropyl)-4,4-diphenylbutadiene. Benzoxazole compounds: 2,4-bis[5-1(dimethylpropyl)benzoxazol-2-yl-(4-phenyl)imino]-6-(2-ethylhexyl)imino-1,3,5-triazine, sold under the name Uvasorb K2A® by the company Sigma 3V.
[0157] The preferred organic shielding agents are: - Ethylhexyl methoxycinnamate, - Ethylhexyl Salicylate, - Homosalate, - butyl methoxydibenzoylmethane, - Octocrylene, - phenylbenzimidazole sulfonic acid, - Benzophenone-3, - Benzophenone-4, - Benzophenone-5, - n-hexyl 2-(4-diethylamino-2-hydroxybenzoyl)benzoate, - 4-methylbenzylidene camphor, - terephthalidenedicamphorsulfonic acid, - disodium phenyldibenzimidazole tetrasulfonate, - methylene bis-benzotriazolyl tetramethylbutylphenol, - bis-ethylhexyloxyphenol methoxyphenyl triazine, - ethylhexyl triazone, - diethylhexylbutamidotriazone, - 2,4,6-tris(dineopentyl 4'-aminobenzalmalonate)-s-triazine, - 2,4,6-tris(diisobutyl 4'-aminobenzalmalonate)-s-triazine, - 2,4-bis(n-butyl 4'-aminobenzoate)-6-(aminopropyltrisiloxane)-s-triazine, - 2,4-bis(dineopentyl 4'-aminobenzalmalonate)-6-(n-butyl 4'-aminobenzoate)-s-triazine, - 2,4-bis(n-butyl 4'-aminobenzalmalonate)-6-[(3-{1,3,3,3-tetramethyl-1-[(trimethylsilyloxy)]disiloxanyl}propyl)amino]-s-triazine, - 2,4,6-tris(diphenyl)triazine, - 2,4,6-tris(terphenyl)triazine, - Drometrizole Trisiloxane, - Polysilicone-15, - 1,1-dicarboxy(2,2'-dimethylpropyl)-4,4-diphenylbutadiene, - 2,4-bis-[5-1(dimethylpropyl)benzoxazol-2-yl-(4-phenyl)-imino]-6-(2-ethylhexyl)imino-1,3,5-triazine, - and mixtures thereof is selected from.
[0158] Particularly preferred organic screening agents are - Ethylhexyl Salicylate, - Homosalate, - butyl methoxydibenzoylmethane, - Octocrylene, - n-hexyl 2-(4-diethylamino-2-hydroxybenzoyl)benzoate, - terephthalidenedicamphorsulfonic acid, - bis-ethylhexyloxyphenol methoxyphenyl triazine, - ethylhexyl triazone, - diethylhexylbutamidotriazone, - 2,4-bis-(n-butyl 4'-aminobenzalmalonate)-6-[(3-{1,3,3,3-tetramethyl-1-[(trimethylsilyloxy]disiloxanyl}propyl)amino]-s-triazine, - Drometrizole Trisiloxane, - and mixtures thereof is selected from.
[0159] The inorganic UV filters used according to the invention are metal oxide pigments. More preferentially, they are metal oxide particles with an average primary particle size of less than or equal to 0.5 μm, more preferentially between 0.005 and 0.5 μm, more preferentially between 0.01 and 0.2 μm, even better between 0.01 and 0.1 μm, more particularly between 0.015 and 0.05 μm.
[0160] They may in particular be chosen from titanium oxide, zinc oxide, iron oxide, zirconium oxide and cerium oxide, or mixtures thereof.
[0161] Such coated or uncoated metal oxide pigments are described, in particular, in patent application EP 0 518 773. Commercially available pigments include products sold by Sachtleben Pigments, Tayca, Merck and Degussa.
[0162] The metal oxide pigments can be coated or uncoated.
[0163] Coated pigments are pigments that have undergone one or more surface treatments of a chemical, electronic, mechanochemical, and / or mechanical nature with compounds such as amino acids, beeswax, fatty acids, fatty alcohols, anionic surfactants, lecithin, sodium, potassium, zinc, iron, or aluminum salts of fatty acids, metal alkoxides (of titanium or aluminum), polyethylene, silicones, proteins (collagen, elastin), alkanolamines, silicon oxide, metal oxides, or sodium hexametaphosphate.
[0164] The coated pigment is more specifically - titanium dioxide coated with silica, for example the product Sunveil® from Ikeda; - titanium dioxide coated with silica and iron oxide, for example the product Sunveil F® from the company Ikeda; titanium dioxide coated with silica and alumina, such as the products Microtitanium Dioxide MT 500 SA® and Microtitanium Dioxide MT 100 SA® from the company Tayca, and the product Tioveil from the company Tioxide; - titanium dioxide coated with alumina, for example the products Tipaque TTO-55(B)(registered trademark) and Tipaque TTO-55(A)(registered trademark) from Ishihara and UVT 14 / 4 from Sachtleben Pigments; titanium dioxide coated with alumina and aluminium stearate, such as the products Microtitanium Dioxide MT 100 T®, MT 100 TX®, MT 100 Z® and MT-01® from the company Tayca, the products Solaveil CT-10 W® and Solaveil CT 100® from the company Uniqema and the product Eusolex T-AVO® from the company Merck; - titanium dioxide coated with silica, alumina and alginic acid, such as the product MT-100 AQ® from the company Tayca; titanium dioxide coated with alumina and aluminium laurate, such as the product Microtitanium Dioxide MT 100 S® from the company Tayca; titanium dioxide coated with iron oxide and iron stearate, such as the product Microtitanium Dioxide MT 100 F® from the company Tayca; - titanium dioxide coated with zinc oxide and zinc stearate, for example the product BR 351® from the company Tayca; titanium dioxide coated with silica and alumina and treated with silicone, in particular the products Microtitanium Dioxide MT 600 SAS®, Microtitanium Dioxide MT 500 SAS® or Microtitanium Dioxide MT 100 SAS® from the company Tayca; - titanium dioxide coated with silica, alumina and aluminium stearate and treated with silicone, for example the product STT-30-DS® from Titan Kogyo, - titanium dioxide coated with silica and treated with silicone, for example the product UV-Titan X 195® from the company Sachtleben Pigments; titanium dioxide coated with alumina and treated with silicone, such as the product Tipaque TTO-55(S)® from Ishihara or the product UV Titan M 262® from Sachtleben Pigments, - Titanium dioxide coated with triethanolamine, for example Titan Kogyo's product STT-65-S; - titanium dioxide coated with stearic acid, for example the product Tipaque TTO-55(C) (registered trademark) from the company Ishihara; - titanium dioxide coated with sodium hexametaphosphate, for example the product Microtitanium Dioxide MT 150 W® from the company Tayca; - TiO2 treated with octyltrimethylsilane, sold under the trade name T 805® by the company Degussa Silices; - TiO2 treated with polydimethylsiloxane, such as that sold by the company Cardre under the trade name 70250 Cardre UF TiO2SI3®; - anatase / rutile TiO2 treated with polydimethylhydrogensiloxane, sold under the trade name Microtitanium Dioxide USP Grade Hydrophobic® by Color Techniques, Inc. - TiO2 coated with triethylhexanoin, aluminum stearate and alumina, sold under the trade name Solaveil CT-200-LQ-(WD) by the company Croda, - TiO2 coated with aluminium stearate, alumina and silicone, sold under the trade name Solaveil CT-12W-LQ-(WD) by the company Croda; - TiO2 coated with lauroyl lysine, sold under the trade name LL 5 Titanium Dioxide CR 50 by Daito Kasei Kogyo Co., Ltd. - Fluoro C9~C 15 TiO2 coated with alcoholic phosphoric acid and aluminum hydroxide, sold under the trade name PFX-5 TiO2CR-50 by Daito Kasei Kogyo Co. It is.
[0165] Mention may also be made of TiO2 pigments doped with at least one transition metal, such as iron, zinc or manganese, more particularly manganese. Preferably, the doped pigment is in the form of an oil dispersion. The oil present in the oil dispersion is preferably selected from triglycerides, including capric / caprylic triglyceride. The oil dispersion of titanium dioxide particles may further comprise one or more dispersants, such as sorbitan esters, such as sorbitan isostearate, or polyoxyalkylenated fatty acid esters of glycerol, such as TRI-PPG-3 myristyl ether citrate and polyglyceryl-3 polyricinoleate. Preferably, the oil dispersion of titanium dioxide particles comprises at least one dispersant selected from polyoxyalkylenated fatty acid esters of glycerol. More specifically, mention may be made of an oily dispersion of manganese-doped TiO2 particles in capric / caprylic triglyceride in the presence of TRI-PPG-3 myristyl ether citrate and polyglyceryl-3 polyricinoleate and sorbitan isostearate, with the INCI name: Titanium dioxide (and) Tri-PPG-3 myristyl ether citrate (and) Polyglyceryl-3 polyricinoleate (and) Sorbitan isostearate, such as the product sold under the trade name Optisol TD50® by Croda.
[0166] Uncoated titanium oxide pigments are sold, for example, by Tayca under the trade names Microtitanium Dioxide MT 500 B or Microtitanium Dioxide MT 600 B (registered trademark), by Degussa under the name P 25, by Wacker under the name Transparent titanium oxide PW (registered trademark), by Miyoshi Kasei under the name UFTR (registered trademark), by Tomen under the name ITS (registered trademark) and by Tioxide under the name Tioveil AQ.
[0167] Uncoated zinc oxide pigments are, for example: - sold under the name Z-Cote by Sunsmart, - sold under the name Nanox® by the company Elementis, - Sold under the name Nanogard WCD 2025® by Nanophase Technologies It is.
[0168] Coated zinc oxide pigments are, for example, - sold under the name Zinc Oxide CS-5® by the company Toshibi (ZnO coated with polymethylhydrogensiloxane); - sold under the name Nanogard Zinc Oxide FN® by Nanophase Technologies (Finsolv TN®, C 12 ~C 15 as a 40% dispersion in benzoic acid esters of alcohol), - those sold by the company Daito under the names Daitopersion ZN-30® and Daitopersion ZN-50® (dispersions in cyclopolymethylsiloxane / oxyethylenated polydimethylsiloxane containing 30% or 50% zinc oxide coated with silica and polymethylhydrogensiloxane); - sold under the name NFD Ultrafine ZnO® by the company Daikin (ZnO coated with a copolymer based on perfluoroalkyl phosphates and perfluoroalkylethyls, as a dispersion in cyclopentasiloxane); - sold under the name SPD-Z1® by the company Shin-Etsu (ZnO coated with a silicone-grafted acrylic polymer dispersed in cyclodimethylsiloxane); - sold under the name Escalol Z100® by the company ISP (ZnO treated with alumina, dispersed in a mixture of ethylhexyl methoxycinnamate / PVP-hexadecene copolymer / methicone); - sold under the name Fuji ZnO-SMS-10® by the company Fuji Pigment (ZnO coated with silica and polymethylsilsesquioxane); - sold under the name Nanox Gel TN® by the company Elementis (C containing polycondensates of hydroxystearic acid 12 ~C 15 ZnO dispersed at 55% concentration in benzoic acid ester of alcohol It is.
[0169] The uncoated cerium oxide pigments may be, for example, those sold under the name Colloidal Cerium Oxide® by the company Rhone-Poulenc.
[0170] Uncoated iron oxide pigments are, for example, sold under the names Nanogard WCD 2002® (FE 45B®), Nanogard Iron FE 45 BL AQ, Nanogard FE 45R AQ®, and Nanogard WCD 2006® (FE 45R) by the company Arnaud or under the name TY-220® by the company Mitsubishi.
[0171] Coated iron oxide pigments are also sold, for example, by the company Arnaud under the names Nanogard WCD 2008 (FE 45B FN®), Nanogard WCD 2009® (FE 45B 556®), Nanogard FE 45 BL 345®, and Nanogard FE 45 BL®, or by the company BASF under the name Transparent Iron Oxide®.
[0172] Mention may also be made of mixtures of metal oxides, in particular mixtures of titanium dioxide and cerium dioxide, such as an equal weight mixture of titanium dioxide and cerium dioxide coated with silica, such as that sold under the name Sunveil A® by the company Ikeda, and mixtures of titanium dioxide and zinc dioxide coated with alumina, silica and silicone, such as the product M 261® sold by the company Sachtleben Pigments, or mixtures of titanium dioxide and zinc dioxide coated with alumina, silica and glycerol, such as the product M 211® sold by the company Sachtleben Pigments.
[0173] According to the invention, coated or uncoated titanium oxide pigments are particularly preferred.
[0174] According to one preferred embodiment, the composition comprises one or more lipophilic UV filters.
[0175] According to one preferred embodiment, the composition comprises one or more UV filters chosen from lipophilic UVA filters and / or lipophilic UVB filters.
[0176] More preferentially, the composition comprises one or more UV filters chosen from dibenzoylmethane derivatives, salicylic acid derivatives, β,β'-diphenylacrylate derivatives, triazine derivatives and benzylidene camphor derivatives.
[0177] According to one particularly preferred embodiment, the composition comprises one or more UV filters selected from terephthalidenedicamphorsulfonic acid, butyl methoxybenzoylmethane, homosalate, ethylhexyl salicylate, octocrylene, ethylhexyl triazone, and mixtures thereof.
[0178] According to one embodiment, the amount of organic UV filters present in the composition according to the invention may range from 0.5% to 50% by weight relative to the total weight of the composition, for example from 1% to 40% by weight, or else for example from 5% to 35% by weight, further for example from 10% to 35% by weight, relative to the total weight of the composition.
[0179] According to one particular embodiment, the concentration of UV screening agent in the composition according to the invention ranges from 1% to 50% by weight, preferably from 1% to 40% by weight relative to the total weight of the composition.
[0180] According to one particular embodiment, the composition according to the invention comprises at least one mineral UV screening agent.
[0181] According to one particular embodiment, the amount of mineral UV filters present in the composition according to the invention may range from 0.01% to 20% by weight relative to the total weight of the composition, for example from 1% to 15% by weight relative to the total weight of the composition.
[0182] According to a particular embodiment, the composition according to the invention also comprises one or more organic UV filters and one or more mineral UV filters.
[0183] According to one particular embodiment, the composition according to the invention also comprises a combination of UV filters as described in French patent No. 2977490, in application WO2013 / 004777 or in application US2014 / 0134120.
[0184] Surfactants According to a preferred embodiment, the composition according to the invention may also comprise at least one surfactant.
[0185] Surfactants can be selected from nonionic, anionic, cationic and amphoteric surfactants, and mixtures thereof.For definition of emulsifying properties and functions of surfactants, refer to Kirk-Othmer, "Encyclopedia of Chemical Technology", Vol. 22, pp. 333-432, 3rd Edition, 1979, Wiley, and for anionic, amphoteric and nonionic surfactants, refer in particular to pages 347-377 of this document.
[0186] Nonionic Surfactants Preferably, the composition according to the invention comprises at least one non-ionic surfactant.
[0187] The nonionic surfactants may in particular be chosen from alkyl and polyalkyl esters of poly(ethylene oxide), oxyalkylenated alcohols, alkyl and polyalkyl ethers of poly(ethylene oxide), optionally polyoxyethylenated alkyl and polyalkyl esters of sorbitan, optionally polyoxyethylenated alkyl and polyalkyl ethers of sorbitan, alkyl and polyalkyl glycosides or polyglycosides, in particular alkyl and polyalkyl glucosides or polyglucosides, alkyl and polyalkyl esters of sucrose, glyceryl esters, optionally polyoxyethylenated alkyl and polyalkyl esters of glycerol, optionally polyoxyethylenated alkyl and polyalkyl ethers of glycerol, zwitterionic surfactants, cetyl alcohol, stearyl alcohol, and mixtures thereof.
[0188] As glyceryl esters, in particular, C 16 ~C 22 Fatty acid esters, specifically glyceryl esters of fatty acids having 18 carbon atoms, and polyglyceryl esters of fatty acids containing 8 to 12 carbon atoms, can be mentioned.
[0189] In particular, C can be mentioned. 18Glyceryl esters of fatty acids include glyceryl stearate (glyceryl monostearate, distearate, and / or tristearate) (CTFA name: glyceryl stearate) or glyceryl ricinoleate, and mixtures thereof.
[0190] Among the fatty acid esters of glycerol, mention may be made of mixtures based on glyceryl stearate, such as those containing glyceryl stearate and OE polyethylene glycol 100 monostearate, as well as the 50 / 50 mixture sold in particular under the name Arlacel 165® by the company Croda, or else containing glyceryl stearate (glyceryl mono-distearate) and potassium stearate, as sold under the name Tegin® (CTFA name: Glyceryl Stearate SE) by the company Goldschmidt.
[0191] Preferably, the composition according to the invention comprises at least one surfactant, in particular a non-ionic surfactant, preferably chosen from glyceryl esters.
[0192] Anionic Surfactants Anionic surfactants include alkyl sulfates, carboxylates, amino acid derivatives, sulfonates, isethionates, taurates, sulfosuccinates, alkyl sulfoacetates, phosphates and alkyl phosphates, polypeptides, C 10 ~C 30 , especially C 16 ~C 25 They may be selected from metal salts of fatty acids, particularly metal stearates and behenylates, alkali metal cetyl phosphates, and mixtures thereof.
[0193] As an alkali metal salt of cetyl phosphate, mention may in particular be made of potassium cetyl phosphate. In particular, the monopotassium salt of monocetyl phosphate (INCI name: potassium cetyl phosphate) sold under the name "Amphisol K" by the company DSM Nutritional Products may be used.
[0194] Cationic Surfactants Cationic surfactants include alkyl imidazolidinium, such as isostearyl ethyl midonium ethosulfate, ammonium salts, such as (C 12~30 -alkyl)-tri(C 1~4 -alkyl)ammonium halides, for example N,N,N-trimethyl-1-docosanium chloride (or behentrimonium chloride).
[0195] Amphoteric surfactants The compositions according to the invention may also contain one or more amphoteric surfactants, such as N-acylamino acids, such as N-alkylaminoacetates and disodium cocoamphodiacetate, and amine oxides, such as stearamine oxide, or silicone surfactants, such as dimethicone copolyol phosphate, for example the product sold under the name Pecosil PS 100® by Phoenix Chemical.
[0196] Silicone Surfactants The composition may also contain at least one silicone surfactant. For example, as a non-ionic surfactant having an HLB of 8 or more at 25° C., used alone or in a mixture, dimethicone copolyol or dimethicone copolyol benzoate can be mentioned, as a non-ionic surfactant having an HLB of less than 8 at 25° C., used alone or in a mixture, cyclomethicone / dimethicone copolyol mixture can be mentioned.
[0197] Preferably, the composition according to the invention comprises less than 2% by weight of a silicone surfactant, in particular less than 1% by weight of a silicone surfactant, preferably less than 0.5% by weight of a silicone surfactant, and more preferentially no silicone surfactant.
[0198] The surfactant may be present in the composition according to the present invention in a proportion ranging from 0.5% to 10% by mass, preferably from 0.5% to 5% by mass, relative to the total mass of the composition.
[0199] Gelling Agents / Thickeners Depending on the flowability of the composition that it is desired to obtain, one or more thickening and / or gelling agents, in particular those that are hydrophilic, i.e. water-soluble or water-dispersible, may be incorporated into the composition.
[0200] Examples of hydrophilic gelling agents that may be mentioned include modified or unmodified carboxyvinyl polymers, such as the products sold under the names Carbopol (CTFA name: Carbomer) and Pemulen (CTFA name: Acrylates / C10-30 Alkyl Acrylate Crosspolymer) by the company Goodrich; polyacrylamido; optionally crosslinked and / or neutralized 2-acrylamido-2-methylpropanesulfonic acid polymers and copolymers, such as poly(2-acrylamido-2-methylpropanesulfonic acid) sold under the name Hostacerin AMPS (CTFA name: Ammonium Polyacryldimethyltauramide) by the company Hoechst; crosslinked anionic copolymers of acrylamide and AMPS, in the form of a W / O emulsion, such as those sold under the names Sepigel 305 (CTFA name: Polyacrylamide / C13-14 Isoparaffin / Laureth-7) and Simulgel 305 (CTFA name: Polyacrylamide / C13-14 Isoparaffin / Laureth-7) by the company SEPPIC. 600 (sold under the CTFA name: Acrylamide / Sodium Acryloyldimethyltartrate Copolymer / Isohexadecane / Polysorbate 80); polysaccharide biopolymers such as xanthan gum, guar gum, alginates, and modified celluloses, and mixtures thereof. The amount of gelling agent depends on the desired purpose.
[0201] According to one embodiment, the amount of gelling agent ranges, for example, from 0.01% to 10% by weight, such as from 0.05% to 5% by weight relative to the total weight of the composition.
[0202] Filler According to one particular embodiment, the composition according to the invention may also further comprise one or more fillers, in particular those chosen from those conventionally used in care and / or makeup compositions.
[0203] For the purposes of the present invention, the term "fillers" is understood to mean colorless or white, mineral or organic, natural or synthetic solid particles of any form, insoluble in the medium of the composition and in a form dispersible therein.
[0204] Of course, these fillers are used in appropriate amounts and under appropriate conditions so as not to be detrimental to the properties of the composition.
[0205] These fillers make it possible to impart softness, mattness and uniformity to the compositions containing them, and in addition, they advantageously make it possible to resist various attacking agents such as sebum or sweat.
[0206] Illustrative of these fillers are talc, mica, silica, kaolin, poly-β-alanine powder and polyethylene powder, tetrafluoroethylene polymer (Teflon®) powder, lauroyl lysine, starch, boron nitride, hollow polymer microspheres such as those of polyvinylidene chloride / acrylonitrile, e.g. Expancel® (Nobel Industrie), acrylic acid copolymer microspheres, silicone resin microbeads (e.g. Tospearls® from Toshiba), polyorganosiloxane elastomer particles, precipitated calcium carbonate, magnesium carbonate, magnesium bicarbonate, hydroxyapatite, barium sulfate, aluminum oxide, polyurethane powder, composite fillers, hollow silica microspheres, and glass or ceramic microcapsules. Also usable are particles in the form of hollow sphere portions, as described in the patent applications JP 2003-128788 and JP 2000-191789.
[0207] Coloring agent The composition according to the invention may also comprise at least one particulate or non-particulate, water-soluble or water-insoluble colorant, preferably in a proportion of at least 0.0001% by weight relative to the total weight of the composition.
[0208] For obvious reasons, this amount is likely to vary significantly with respect to the strength of the color effect desired and the strength of the color imparted by the colorant under consideration, the adjustment of which is clearly within the capabilities of one skilled in the art.
[0209] As mentioned above, colorants suitable for use in the present invention can be water-soluble, but can also be oil-soluble.
[0210] water soluble dye For purposes of the present invention, the term "water-soluble colorant" means any natural or synthetic, generally organic compound that is soluble in an aqueous phase or a water-miscible solvent and capable of imparting color.
[0211] Suitable water-soluble dyes for use in the present invention include, in particular, synthetic or natural water-soluble dyes such as FDC Red 4, DC Red 6, DC Red 22, DC Red 28, DC Red 30, DC Red 33, DC Orange 4, DC Yellow 5, DC Yellow 6, DC Yellow 8, FDC Green 3, DC Green 5, FDC Blue 1, betanin (beetroot), carmine, copper chlorophyllin, methylene blue, anthocyanins (enocyanin, black carrot, hibiscus, elderberry), caramel, as well as riboflavin.
[0212] Water-soluble dyes are, for example, beetroot juice and caramel.
[0213] According to a preferred embodiment, the composition according to the invention comprises at least one water-soluble dye.
[0214] The water-soluble dye may be present in a proportion of 0.0001% to 2% by weight relative to the total weight of the composition containing it.
[0215] fat soluble dye For the purposes of the present invention, the term "liposoluble colorant" is intended to mean any natural or synthetic, generally organic compound, which is soluble in a solvent miscible with an oily phase or with fatty substances and is capable of imparting color.
[0216] Suitable fat-soluble dyes for use in the present invention include, in particular, synthetic or natural fat-soluble dyes such as DC Red 17, DC Red 21, DC Red 27, DC Green 6, DC Yellow 11, DC Violet 2, DC Orange 5, Sudan red, carotenes (β-carotene, lycopene), xanthophylls (capsanthin, capsorubin, lutein), palm oil, Sudan brown, quinoline yellow, annatto, and curcumin.
[0217] The colouring particulate material may be present in a proportion of 0.0001% to 10% by weight, based on the total weight of the composition in which it is contained.
[0218] They may in particular be particles having pigments, pearlescent agents and / or metallic shades.
[0219] Pigments The term "pigments" should be understood to mean white or colored mineral or organic particles, insoluble in aqueous solutions, intended to color and / or opacify the compositions containing them.
[0220] The pigments may be white or colored and may be mineral and / or organic.
[0221] Mineral pigments may include titanium oxide, titanium dioxide, zirconium oxide, zirconium dioxide, cerium oxide or cerium dioxide, as well as zinc oxide, iron oxide or chromium oxide, ferric blue, manganese violet, ultramarine blue, and chromium hydrate, and mixtures thereof.
[0222] They may also be pigments with a structure that may be, for example, of the sericite / brown iron oxide / titanium dioxide / silica type. Such pigments are, for example, sold under the reference Coverleaf NS or JS by the company Chemicals and Catalysts and have a contrast ratio in the region of 30.
[0223] They may also be pigments with a structure that may be, for example, of the silica microsphere type containing iron oxide.An example of a pigment with this structure is the product sold by the company Miyoshi under the reference PC Ball PC-LL-100 P, which pigment is composed of silica microspheres containing yellow iron oxide.
[0224] Advantageously, the pigments may be iron oxide and / or titanium dioxide.
[0225] According to one particular embodiment, the composition according to the invention comprises less than 1% by weight of pigments.
[0226] Pearlizing Agent The term "pearlescent agent" should be understood to mean any form of colored particle, which may or may not be iridescent, especially produced by certain mollusks in their shells or alternatively synthesized, and which has a color effect due to optical interference.
[0227] The pearlescent agents can be chosen from pearlescent pigments, such as titanium oxide-coated mica covered with iron oxide, titanium oxide-coated mica covered with bismuth oxychloride, titanium oxide-coated mica covered with chromium oxide, titanium oxide-coated mica covered with organic dyes, and also pearlescent pigments based on bismuth oxychloride. They may also be mica particles on the surface of which at least two successive layers of metal oxide and / or organic colorants are superimposed.
[0228] Examples of pearlescent agents that may further be mentioned include titanium oxide, iron oxide, natural pigments or natural mica coated with bismuth oxychloride.
[0229] Among the commercially available pearlescent agents, mention may be made, inter alia, of the pearlescent agents Timica, Flamenco, and Duochrome (mica-based) sold by Engelhard, the pearlescent agent Timiron sold by Merck, the mica-based pearlescent agent Prestige sold by Eckart, and the synthetic mica-based pearlescent agent Sunshine sold by Sun Chemical.
[0230] The pearlescent agent may more specifically have a yellow, pink, red, bronze, orange, brown, gold, and / or copper color or hue.
[0231] Advantageously, the pearlescent agent according to the invention is mica coated with titanium dioxide or iron oxide, and also with bismuth oxychloride.
[0232] According to one particular embodiment, the composition according to the invention comprises less than 1% by weight of pearlescent agent.
[0233] Particles with metallic hues For the purposes of the present invention, the term "particles having a metallic hue" means any compound whose nature, size, structure and surface finish enable it to reflect incident light in a specifically non-iridescent manner.
[0234] The particles with a metallic hue that can be used in the present invention are in particular chosen from particles of at least one metal and / or at least one metal derivative, particles made from a single material or from a plurality of materials and comprising an organic or mineral matrix at least partially covered with at least one layer having particles with a metallic hue comprising at least one metal and / or at least one metal derivative, and mixtures of said particles.
[0235] Among the metals that may be present in the particles, mention may be made, for example, of Ag, Au, Cu, Al, Ni, Sn, Mg, Cr, Mo, Ti, Zr, Pt, Va, Rb, W, Zn, Ge, Te, and Se, as well as mixtures or alloys thereof. Preferred metals are Ag, Au, Cu, Al, Zn, Ni, Mo, and Cr, as well as mixtures or alloys thereof (e.g. bronze and brass).
[0236] The term "metal derivatives" refers to compounds derived from metals, specifically oxides, fluorides, chlorides, and sulfides.
[0237] Examples of these particles that may be mentioned include aluminum particles, such as those sold under the name Starbrite 1200 EAC® by the company Siberline and those sold under the name Metalure® by the company Eckart, and glass particles coated with a metal layer, in particular those described in JP-A-09-188830, JP-A-10-158450, JP-A-10-158541, JP-A-07-258460 and JP-A-05-017710.
[0238] According to one particular embodiment, the composition according to the invention comprises particles with a metallic hue of less than 1%.
[0239] Hydrophobic treatment of colorants The above-mentioned powder colorants can be totally or partially surface-treated with hydrophobic agents to make them more compatible with the oil phase of the composition of the present invention, in particular so that they have good wetting with oil. These treated pigments are therefore better dispersed in the oil phase. Hydrophobically treated pigments are described in particular in EP-A-1086683.
[0240] The hydrophobic treatment agent may be selected from silicones such as methicone, dimethicone, and perfluoroalkyl silanes; fatty acids such as stearic acid; metal soaps such as aluminum dimyristate, aluminum salt of hydrogenated tallow glutamate; perfluoroalkyl phosphates; hexafluoropropylene polyoxide; perfluoropolyethers; amino acids; N-acyl amino acids or salts thereof; lecithin; isopropyl triisostearyl titanate, isostearyl sebacate, and mixtures thereof.
[0241] The term "alkyl" referred to in the above cited compounds refers in particular to alkyl groups containing from 1 to 30 carbon atoms, preferably containing from 5 to 16 carbon atoms.
[0242] Additives The compositions according to the invention may also comprise conventional cosmetic adjuvants, in particular those selected from active agents, emollients, wetting agents, opacifiers, emollients, silicones, antifoaming agents, fragrances, polar additives, preservatives, in particular phenoxyethanol, polymers, such as film-forming polymers, propellants, dispersants, anti-soiling agents, chelating agents, basifying or acidifying agents, or any other ingredient commonly used in the cosmetic and / or dermatological fields.
[0243] Among the acidifying agents, examples that may be mentioned include mineral or organic acids, such as hydrochloric acid, orthophosphoric acid, sulfuric acid, carboxylic acids, such as acetic acid, tartaric acid, citric acid or lactic acid, and sulfonic acids.
[0244] Among the basifying agents, examples that may be mentioned include aqueous ammonia, alkali metal carbonates, alkanolamines such as mono-, di- and triethanolamine and their derivatives, sodium hydroxide or potassium hydroxide.
[0245] Preferably, the cosmetic composition comprises one or more basifying agents selected from alkanolamines, in particular triethanolamine, and sodium hydroxide.
[0246] In the case of direct emulsions, the pH of the compositions according to the invention is generally between about 3 and 12, preferably between about 5 and 11, and even more particularly between 5.5 and 8.
[0247] Among the active agents for caring for keratinous materials, such as the skin, lips, scalp, hair, eyelashes or nails, there are, inter alia: vitamins and their derivatives or precursors, alone or in mixtures; antioxidants; free radical scavengers; antipollutants; self-tanning agents; antiglycation agents; soothing agents; deodorants; essential oils; NO synthase inhibitors; agents for stimulating the synthesis and / or preventing the degradation of dermal or epidermal macromolecules; agents for stimulating fibroblast proliferation; agents for stimulating keratinocyte proliferation; muscle relaxants; cooling agents; tensioning agents; mattifying agents; depigmenting agents; pigmentation promoters; keratolytic agents; desquamating agents; moisturizing agents; anti-inflammatory agents; antimicrobial agents; thinning agents. agents acting on cellular energy metabolism; insect repellents; substance P antagonists or CRGP antagonists; hair loss prevention agents; anti-wrinkle agents; and anti-aging agents.
[0248] The person skilled in the art will select the active agent as a function of the desired effect on the skin, hair, eyelashes, eyebrows or nails.
[0249] Of course, the skilled artisan will take care to select this or these optional additional compounds, and / or the amounts thereof, such that the advantageous properties of the compositions according to the invention are not adversely affected or are not substantially affected by the envisaged addition.
[0250] composition The composition according to the invention may be in the form of an emulsion, e.g. an oil-in-water (O / W) or water-in-oil (W / O) emulsion, a gel, e.g. an oil-in-water or water-in-oil emulsified gel, an aqueous composition or else a gel / gel type composition.
[0251] According to one embodiment, the composition according to the invention is an emulsion.
[0252] According to one variant, the composition according to the invention is a single-phase emulsion.
[0253] According to one variant, the composition according to the invention is a multiple emulsion. It may also be a triple emulsion.
[0254] According to one variant, the composition according to the invention is a normal single emulsion. Thus, according to one embodiment, the composition according to the invention is an oil-in-water (O / W) emulsion.
[0255] According to one variant, the composition according to the invention is an inverse single emulsion. Thus, according to one embodiment, the composition according to the invention is a water-in-oil (W / O) emulsion.
[0256] According to one variant, the composition according to the invention is an aqueous formulation of the aqueous gel or solution type.
[0257] Preferably the composition is an emulsion, in particular a water-in-oil or oil-in-water emulsion.
[0258] For compositions in the form of oil-in-water or water-in-oil emulsions, emulsification methods that can be used are those of the paddle or propeller, rotor-stator and HPH type.
[0259] To obtain stable emulsions at low polymer contents (oil / polymer ratio >25), it is possible to prepare a dispersion in the concentrated phase and then dilute the dispersion with the remaining aqueous phase.
[0260] Also via HPH (between 50 and 800 bar) stable dispersions can be obtained with droplet sizes that can be as small as 100 nm.
[0261] The composition according to the invention may be more or less fluid and may have the appearance of a white or colored cream, an ointment, a milk, a lotion, a serum, a paste or a foam. It may optionally be applied to the skin in the form of an aerosol. It may also be in solid form, for example in the form of a stick.
[0262] The composition according to the invention may be in the form of a cosmetic composition for caring for and / or making up keratinous materials, preferably a cosmetic composition for caring for keratinous materials, in particular keratinous materials of the body or face, preferably of the face.
[0263] The compositions according to the invention find application in a large number of treatments, in particular cosmetic treatments, for the skin, lips and hair (including the scalp), in particular for protecting and / or caring for the skin, lips and / or hair and / or for making up the skin and / or lips.
[0264] Another subject of the invention consists of the use of the composition according to the invention as defined above, in the manufacture of products for the cosmetic treatment of the skin, lips, nails, hair, eyelashes, eyebrows and / or scalp, in particular care products, sun protection products and make-up products.
[0265] The compositions according to the invention may be in the form of a product for caring for the skin or semi-mucous membranes, for example a protective or cosmetic care composition for the face, lips, hands, feet, anatomical folds or body (for example a day cream, a night cream, a day serum, a night serum, a make-up removal cream, a make-up base, a sunscreen composition, a protective or caring body milk, an after-sun milk, a skin care or scalp care lotion, a gel or foam, a serum, a mask or an aftershave composition).
[0266] The cosmetic compositions according to the invention can be used, for example, as face and / or body care and / or sun protection products having a liquid to semi-liquid consistency, such as lotions, milks, more or less thick creams, gels and cream-gels, which can optionally be packaged as aerosols and can be provided in the form of foams or sprays.
[0267] The composition according to the present invention in the form of the evaporative fluid lotion according to the present invention is applied to skin or hair in the form of fine particles by a pressurized device.The device according to the present invention is well known to those skilled in the art, and includes non-aerosol pumps or "atomizers", aerosol containers containing propellants, and aerosol pumps that use compressed air as propellant.These devices are described in US Patent Nos. 4,077,441 and 4,850,517.
[0268] The compositions packaged in the form of an aerosol according to the invention generally contain conventional propellants, such as hydrofluorocompounds, dichlorodifluoromethane, difluoroethane, dimethyl ether, isobutane, n-butane, propane or trichlorofluoromethane, which are preferably present in an amount ranging from 15% to 50% by weight relative to the total weight of the composition.
[0269] The composition may be applied to the skin by hand or using an applicator.
[0270] According to another aspect, the present invention provides a method for producing a method for manufacturing a pharmaceutical composition comprising: i) a container divided into one or more compartments, closed by a closure member and optionally unsealed; ii) a makeup and / or care composition according to the invention contained in said compartment; The present invention also relates to a cosmetic assembly comprising:
[0271] The container may be in the form of, for example, a bottle or a case.
[0272] The closure member may be in the form of a lid comprising a cap mounted so as to be movable by translation or by pivoting relative to a container containing said makeup and / or care composition.
[0273] Such compositions are in particular prepared according to the general knowledge of the person skilled in the art.
[0274] Such a composition as defined above may in particular be utilized for cosmetic use according to the invention.
[0275] The present invention therefore also relates to the use of a composition according to the invention for the care and / or make-up of keratinous materials, preferably for the care of keratinous materials, in particular the skin of the body and / or face.
[0276] The present invention also relates to a cosmetic method for making up and / or caring for keratinous materials, in particular the skin, comprising at least one step of applying a composition as defined above to said keratinous materials.
[0277] Preferably, the present invention also relates to a cosmetic method for caring for keratinous materials, in particular keratinous materials of the body and / or face, comprising at least one step of applying a composition as defined above to said keratinous materials.
[0278] Cosmetic methods for making up and / or caring for keratinous materials, and in particular the skin, are non-therapeutic.
[0279] In particular, the invention relates to the non-therapeutic cosmetic use of a composition as described above for protecting keratinous materials, in particular the skin and / or lips and / or hair, against solar radiation.
[0280] The present invention also relates to the non-therapeutic cosmetic use of a composition as defined above for arresting or preventing the signs of premature light-induced ageing of keratinous materials, in particular the skin and / or lips and / or hair.
[0281] According to one embodiment, the present invention also relates to the use of a composition according to the invention for reducing pigmentation induced by UVA, UVB and long wave UVA radiation.
[0282] The present invention also relates to the cosmetic use of a composition as defined above for preventing skin darkening and / or for improving the colour and / or evenness of the facial skin.
[0283] In addition, the present invention relates to the cosmetic use of a composition as defined above for preventing the signs of premature aging, in particular of skin aging of actinic origin, such as photoaging, of keratinous materials, in particular of the skin, in particular of the face, around the neck, arms, hands and / or shoulders.
[0284] The present invention also relates to the cosmetic use of a composition as defined above for preventing loss of skin firmness and / or elasticity and / or tautness and / or flexibility, the formation of wrinkles and fine lines, dullness of the facial skin and / or the appearance of wrinkled skin.
[0285] The present invention also relates to a non-therapeutic cosmetic method for protecting keratinous materials, in particular the skin and / or lips and / or hair, from solar radiation, which comprises the application to the surface of the keratinous materials of at least one composition according to the invention.
[0286] It also relates to a non-therapeutic cosmetic method for preventing and / or treating the signs of ageing of keratinous materials, comprising the application to the surface of the keratinous materials of at least one composition according to the invention.
[0287] For the purposes of the present invention, the term "prevent" is understood to mean at least partially reducing the risk of the occurrence of a given phenomenon.
[0288] Throughout the description, including the claims, the phrase "including a" should be understood to be synonymous with "including at least one," unless otherwise indicated.
[0289] The expressions "between", "including", "forming from" and "ranging from" should be understood to be inclusive, unless otherwise indicated.
[0290] In the present specification and examples, percentages are percentages by weight unless otherwise indicated. Percentages are therefore expressed by weight relative to the total weight of the composition. Temperatures are expressed in degrees Celsius unless otherwise indicated, and pressures are atmospheric pressure unless otherwise indicated.
[0291] The invention is illustrated in more detail by the non-limiting examples presented below. EXAMPLES
[0292] Example A Preparation of merocyanines according to the present invention
[0293] (Example A1) Preparation of Compound (A)
[0294] [ka]
[0295] 122.23 g of 3-[(3-methoxypropyl)amino]-2-cyclohexen-1-one were alkylated with dimethyl sulfate or alternatively diethyl sulfate and treated with approximately equimolar proportions of 75.45 g of ethyl cyanoacetate in the presence of a base and optionally a solvent.
[0296] The following base / solvent combinations were used:
[0297] [Table 2]
[0298] The completion of the alkylation reaction can be monitored by methods such as TLC, GC or HPLC. 162.30 g of compound (14) are obtained in the form of a brown oil. After crystallization, the product is obtained in the form of yellowish crystals. Melting point: 92.7°C.
[0299] (Example A2) Preparation of compound (B)
[0300] [ka]
[0301] 101.00 g of 3-[(3-methoxypropyl)amino]-2-cyclohexen-1-one was alkylated with dimethyl sulfate or alternatively diethyl sulfate and treated with 86.00 g of 2-cyano-N-(3-methoxypropyl)acetamide in approximately equimolar proportions in the presence of a base and optionally a solvent.
[0302] The following base / solvent combinations were used:
[0303] [Table 3]
[0304] The crude product (B) was obtained in the form of a dark brown oil. After silica gel column chromatography (eluent: 99 / 1 toluene / methanol), 81.8 g of product was obtained in the form of yellowish crystals. Melting point: 84.7~85.3℃.
[0305] (Example A3) Preparation of compound (D)
[0306] [ka]
[0307] 13.09 g of 3-[(3-methoxypropyl)amino]-2-cyclohexen-1-one were alkylated with dimethyl sulfate or alternatively diethyl sulfate and treated with 10.12 g of isobutyl cyanoacetate in the presence of a base and optionally a solvent.
[0308] The following base / solvent combinations were used:
[0309] [Table 4]
[0310] 15.97 g of crude product (27) were obtained in the form of a dark brown oil. After silica gel column chromatography (eluent: toluene / acetone), 13.46 g of product were obtained in the form of yellowish crystals. Melting point: 96.3℃.
[0311] (Example A4) Preparation of compound (C)
[0312] [ka]
[0313] 148.4 g of 3-[(3-methoxypropyl)amino]-2-cyclohexen-1-one was alkylated with dimethyl sulfate or alternatively diethyl sulfate and treated with 130.00 g of 2-ethoxyethyl cyanoacetate in the presence of an organic base and a solvent.
[0314] The following base / solvent combinations were used:
[0315] [Table 5]
[0316] Example 1 Examination of the solubilization of methoxypropylaminocyclohexenylideneethoxyethyl cyanoacetate (C) prepared in Example A4 in saturated single solution A single solution containing an excess of methoxypropylaminocyclohexenylidene ethoxyethyl cyanoacetate blocking agent in various solvents and mixtures of solvents was prepared using the weight proportions detailed in the table below, where the values are expressed as weight percentages relative to the total weight of the composition.
[0317] [Table 6]
[0318] Methoxypropylaminocyclohexenylideneethoxyethyl cyanoacetate shielding agent was assayed to calculate its solubility in various solvents and solvent mixtures. In each of the formulations, the shielding agent is present in 5% excess in order to perform solubility measurements at the same degree of saturation.
[0319] The solutions were 0.2 μm filtered prior to the assay. The assay was carried out at room temperature 72 hours after preparation of the compositions.
[0320] For Formulation 4, an additional assay was performed at room temperature two months after preparation of the composition.
[0321] The assay was performed by HPLC / UV under the following conditions: System: Acquity UPLC from Waters, BEH Shield RP18 column, 1.7 μm (2.1 mm×100 mm), eluent: methanol / H3PO4 acidified water, eluent gradient 0.1%. Samples are prepared by dilution in methanol.
[0322] The results are detailed in the table below.
[0323] [Table 7]
[0324] Solubility measurements show that the water solubility of the methoxypropylaminocyclohexenylidene ethoxyethyl cyanoacetate screening agent (C) is increased in compositions according to the invention containing nicotinamide and / or caffeine compared to formulation 1 which does not contain a hydrotrope.
[0325] This solubility is verified over time, as shown by measurements carried out on composition 4 according to the invention, which remains stable two months after the preparation of the composition.
[0326] The solubility of compound (C) in aqueous media was also examined in the presence of a single hydrotrope and one or more combinations of organic solvents, the nature and mass proportions of which are detailed in Table 5 below. Values are expressed as mass percentages relative to the total mass of the composition.
[0327] Formulations 1A-G were prepared according to the following procedure: - Compound 25 is dissolved in propylene carbonate by heating at 65°C until a clear mixture is obtained. - Cool to approximately 45°C, then introduce the other ingredients and finally add the ethanol. - The mixture is heated again at 65°C. - If a hydrotrope is added (Examples 2, 3, 5, 6, and 7), vortex until a clear mixture is obtained. Leave at 65°C for 1 hour, then return to room temperature for 24 hours. - The mixture is centrifuged at 4000 rpm for 10 minutes to accelerate the phase separation. The mixture is then stored at room temperature and phase separation is observed after 2 weeks.
[0328] [Table 8]
[0329] [Table 9]
[0330] It is observed that the lack of solubility of compound (C) in water (Formulation A) or in aqueous mixtures containing at least one organic solvent (Formulation D) is overcome by the presence of a hydrotrope such as, for example, nicotinamide or sodium salicylate or caffeine.
[0331] Example 2 Composition 6 according to the present invention A composition 6 according to the invention in gel form is prepared using the weight proportions detailed in the table below, the values being expressed as percentages by weight relative to the total weight of the composition.
[0332] [Table 10]
[0333] The composition is prepared according to the following procedure. In a beaker equipped with a Rayneri paddle, mix water, dipropylene glycol, and niacinamide in phase A. When the solution is clear, introduce caffeine, then methoxypropylaminocyclohexenylidene ethoxyethyl cyanoacetate, and leave the solution to stir and heat at 40°C. When the solution is clear, add preservatives, then introduce gelling agent, and leave the composition to swell. Then measure pH and neutralize the composition with NaOH to obtain a pH equal to 6. Then add water in phase D.
[0334] The resulting composition is advantageously a single phase composition.
[0335] Example 3 Compositions 7 and 8 according to the invention Compositions 7 and 8 according to the invention, in the form of oil-in-water emulsions, are prepared using the weight proportions detailed in the table below, the values being expressed as percentages by weight relative to the total weight of the composition.
[0336] [Table 11]
[0337] Composition 7 is prepared according to the following procedure. The ingredients of Phase B1 are mixed in an emulsifier equipped with a Rayneri paddle and homogenized at 70° C. for 10 minutes. The ingredients of Phase A are added at 60° C. for emulsification and the composition is left stirring for 10 minutes. The ingredients of Phases B2, B3, and C are added at 40° C. for gelation. The composition is left stirring for 15 minutes. The composition is cooled to 30° C. The fillers of Phase E are incorporated and the composition is left stirring for 15 minutes.
[0338] [Table 12]
[0339] Composition 8 is prepared according to the following procedure. In a beaker equipped with a Rayneri paddle, mix water, dipropylene glycol, phenoxyethanol, and niacinamide. When the solution is clear, introduce caffeine, then methoxypropylaminocyclohexenylidene ethoxyethyl cyanoacetate, and leave the solution to stir and heat at 40°C. When the solution is clear, add the compounds of phase B1, previously melted at 55°C, for emulsification, then add the ingredients of phase B2. Introduce the ingredients of phase C, then the ingredients of phase D, and leave the composition to swell.
[0340] Compositions 7 and 8 are both single-phase compositions, in other words, compound (C) is incorporated therein in solute form.
[0341] Example 4 Composition 9 Composition 9 is prepared using the weight proportions detailed in the table below, where the values are expressed as weight percentages relative to the total weight of the composition.
[0342] [Table 13]
[0343] procedure: - Phases A1, B1 and C are prepared separately by mixing the ingredients constituting each phase and heating at 65°C under magnetic stirring until a clear mixture is obtained. The ingredients of phase B2 are introduced into phase B1 under stirring until a fine dispersion of potassium cetyl phosphate is obtained. Phase A2 is prepared by dispersing the gelling agent in the glycol, then adding water and mixing with an Ultraturrax mixer at 27 000 rpm for 5 minutes. Phase C is prepared by introducing compound 25 into propylene carbonate under mechanical stirring with heating at 65° C. until a clear mixture is obtained. Then, once the mixture has returned to room temperature, ethanol is incorporated. - Phases A1 and A2 are introduced into phase B1+B2 by mixing with an Ultraturrax mixer at 27 000 rpm for 5 minutes to obtain an emulsion. Phase C is then incorporated by mixing with an Ultraturrax mixer at 27 000 rpm for 5 minutes. Composition 9 is advantageously an emulsion.
Claims
1. A cosmetic or dermatological composition, in particular for making up and / or caring for keratinous materials, comprising at least an aqueous phase and at least one merocyanine of formula (I) and its E / E or E / Z geometric isomeric forms: 【Chemistry 1】 (In the formula, A is -O- or -NH; - R, C 1 ~C 22 Alkyl group, C 2 ~C 22 Alkenyl group, C 2 ~C 22 Alkynyl group, C 3 ~C 22 Cycloalkyl group or C 3 ~C 22 a cycloalkenyl group, which can be interrupted by one or more O; at least one hydrotrope selected from nicotinamide, caffeine, salicylates, sodium salt of pyroglutamic acid (sodium PCA), sodium 1,3-benzenedisulfonate, sodium benzoate, sodium 4-pyridinecarboxylate, sodium benzenesulfonate, sodium p-toluenesulfonate (NaPTS), sodium butylmonoglycol sulfate (NaBMGS), 4-aminobenzoic acid HCl, sodium cumenesulfonate, N,N-diethylnicotinamide, N-picolylnicotinamide, N-allylnicotinamide, 2-methacryloyloxyethylphosphorylcholine, resorcinol, pyrogallol, N-picolylacetamide, procaine HCl, proline HCl, pyridine, 3-picolylamine, sodium ibuprofen, sodium xylenesulfonate (SXS), ethyl carbamate, pyridoxal hydrochloride, sodium benzoate, N,N-dimethylacetamide, N-methylacetamide, isoniazid, and mixtures thereof; 1. A cosmetic or dermatological composition comprising:
2. 2. The composition of claim 1, comprising, as at least one merocyanine of formula (I), at least one compound selected from the following compounds and their E / E or E / Z geometric isomeric forms: 【Table 1A】 【Table 1B】
3. The merocyanine of formula (I) has the following structure in its E / Z geometric configuration: 【Chemistry 2】 and / or its E / E geometric configuration having the structure: 【Chemistry 3】 3. The composition according to claim 1 or 2, wherein the compound is 2-ethoxyethyl (2Z)-cyano{3-[(3-methoxypropyl)amino]cyclohex-2-en-1-ylidene}ethanoate (C) in the formula:
4. 4. The composition according to claim 1, wherein the content of merocyanine of formula (I) ranges from 0.1% to 25% by weight, preferentially from 0.2% to 20% by weight, more preferentially from 0.5% to 10% by weight and even better still from 1% to 5% by weight relative to the total weight of the composition.
5. 5. The composition according to claim 1, comprising at least one hydrotrope selected from nicotinamide, caffeine, and mixtures thereof.
6. Salicylates, sodium salt of pyroglutamic acid (sodium PCA), sodium 1,3-benzenedisulfonate, sodium benzoate, sodium 4-pyridinecarboxylate, sodium benzenesulfonate, sodium p-toluenesulfonate (NaPTS), sodium butyl monoglycol sulfate (NaBMGS), 4-aminobenzoic acid HCl, sodium cumenesulfonate, N,N-diethylnicotinamide, N-picolylnicotinamide, N-allylnicotinamide, 2-methacryloyloxyethylphosphonicotinamide, 6. The composition of claim 5, further comprising at least one additional hydrotrope, preferably at least one salicylate, selected from: arylcholine, resorcinol, pyrogallol, N-picolylacetamide, procaine HCl, proline HCl, pyridine, 3-picolylamine, ibuprofen sodium, sodium xylene sulfonate (SXS), ethyl carbamate, pyridoxal hydrochloride, sodium benzoate, N,N-dimethylacetamide, N-methylacetamide, isoniazid, and mixtures thereof.
7. 7. The composition according to claim 1, comprising at least nicotinamide as a hydrotrope.
8. 8. The composition according to claim 1 , wherein the content of hydrotrope ranges from 0.1% to 20% by weight, in particular from 0.1% to 10% by weight, preferably from 0.5% to 10% by weight, in particular from 0.5% to 3% by weight, relative to the total weight of the composition.
9. 9. The composition according to any one of claims 1 to 8, wherein the mass ratio of merocyanine of formula (I) / hydrotrope ranges from 0.01 to 8, preferably from 0.02 to 5, particularly from 0.05 to 3, more particularly from 0.1 to 1.
5.
10. 10. Composition according to any one of claims 1 to 9, comprising at least two different hydrotropes selected from nicotinamide, caffeine and sodium salicylate, the mass ratio of merocyanine of formula (I) / hydrotrope ranging from 0.01 to 5, preferably from 0.02 to 3, in particular from 0.05 to 2 and more preferentially from 0.1 to 1.
5.
11. 11. The composition according to any one of claims 1 to 10, comprising two different hydrotropes chosen from nicotinamide and caffeine, the mass ratio between these two hydrotropes ranging from 0.2 to 5, in particular from 0.5 to 3 and more preferentially from 0.8 to 1.
2.
12. 12. The composition according to claim 1, comprising at least one alcohol, in particular a monoalcohol, preferably ethanol.
13. 13. The composition according to any one of claims 1 to 12, further comprising at least one alkylene carbonate, preferably propylene carbonate.
14. 14. The composition according to any one of claims 1 to 13, comprising at least one polyol, in particular one selected from ethylene glycol, pentaerythritol, trimethylolpropane, pentylene glycol, propylene glycol, dipropylene glycol (DPG), caprylyl glycol, glycerol, polyglycerols, polyethylene glycols (PEG), and mixtures thereof, in particular one selected from propylene glycol, pentylene glycol, dipropylene glycol, and mixtures thereof, preferably dipropylene glycol.
15. The composition according to any one of the preceding claims, comprising at least one fatty phase, preferably ranging from 0.5% to 80% by weight, preferably from 1% to 40% by weight and more preferentially from 3% to 20% by weight relative to the total weight of the composition.
16. 16. The composition of claim 1, further comprising at least one additional UV filter different from the merocyanine of formula (I).
17. 17. Composition according to any one of the preceding claims, characterized in that it is a cosmetic composition for caring for keratinous materials, in particular keratinous materials of the body or face, preferably of the face.
18. A cosmetic method for caring for keratinous substances, in particular keratinous substances of the body and / or face, comprising at least one step of applying a composition according to any one of claims 1 to 17 to said keratinous substances.
Citation Information
Patent Citations
Cosmetic and / or dermatological compositions containing merocyanine derivatives that include specific polar groups consisting of hydroxyl and ether functional groups.
JP2014529337A
trans-resveratrol or trans-resveratrol derivative composition
JP2016503788A
Carrier system for water-soluble active ingredients
JP2017511808A
Cosmetic or dermatological emulsion comprising a merocyanine and an emulsifying system containing an amphiphilic polymer comprising at least one 2-acrylamidomethylpropanesulfonic acid unit
WO2014111571A1
Composition comprising baicalin and an antioxidant compound
WO2019121636A1
